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VSUMMARY
The hepatocyte growth factor receptor (HGf-R) otherwise known as the c-Met proto
oncogene is involved with various cellular responses such as morphogenesis,
motogenesis, and mitogenesis. Phosphorylation and subsequent activation of the
receptor’s tyrosine kinase domain, through bindïng of hepatocyte growth factor
(HGF), has been shown to trigger various cellular responses via the binding of
different src homology domain 2 (SH2) containing proteins to phosphorylated
tyrosine residues of the multi-functional docking site found in the receptor’s C-
terminal domain.
Various cancer colis express high levels of c-Met phosphorylation, which translates
into high levels of c-Met activity. For this reason, much of the research performed
today with regards to c-Met and its involvernent in tumorigenesis revolves around the
possible mechanisms behind this constitutive autophosphorylation. Some groups
point to the presence of point mutations within the tyrosine kinase domain of c-Met
which leads to its increased activity. Others suggest the existence of an autocrine
activation ioop. In fact, many of the cancers studied to date show evidence of these
two possible phenomena.
In the present study, we wanted to analyze the tumorigenic character of an invasive
variant of Moloney sarcoma virus-transformed MDCK ceils (MSV-MDCK-INV) and
to assess c-Met’s role in this phenotype. Resu!ts dernonstrated that in fact MSV
MDCK-INV cells have the capacity to form foci in soft agar similar in size and at a
very similar efficiency to the turnorigenic NIH3T3/ras ce!! une. Although MDCK
and MSV-MDCK colis formed foci in soft agar, the size and growth efficiency was
small compared to MSV-MDCK-INV cells. Clones isolated from the soft agar were
analyzed for their capacity to form colonies over monolayers of polarized MDCK
ceils. Invasive clones along with NIH3T3/ras clones were the only ones capable of
forming these superficia! colonies. Ce!!s from soft agar clones il!ustrated different
expression levels of certain proteins involved with focal adhesion complexes and
ceil-ceil contacts, nameiy E-cadherin, FAK and paxillin. CAMI-4, one ofthe invasive
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soft agar clones studied, was found to express a more phosphorylated c-Met and a
142% invasive capability when cornpared to the invasive capability expressed by
MSV-MDCK-INV celis. I
The resuÏts presented above support the fact that the MSV-MDCK-INV ccli une
expresses turnorigenic characteristics. Unfortunately though, no point mutations were
observed in either the tyrosine kinase or C-terminal domains of c-Met that could
explain the invasive and tumorigenic characteristics of these celis and the
transformed phenotype observed for MSV-MDCK celis. Therefore, we assume the
existence of an autocrine activation ioop among M$V-MDCK-INV celis that can, at
least in part, explain the auto-phosphorylation of c-Met and the subsequent phenotype
observed.
Key words: HGF -Rie-Met, auto-phosphorylation, invasive, tumorigenic, soft agar,
MDCK, mutation, tyrosine kinase.
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SOMMAIRE
Le récepteur du facteur de croissance hépatique (HGF-R), reconnu aussi comme le
proto-oncogène c-Met, est impliqué dans plusieurs réponses cellulaires telles que la
morphogenèse, la motogenèse et la mitogenèse. La liaison du facteur de croissance
hépatique (HGf) à son récepteur mène à la phosphorylation et à l’activation du
domaine tyrosine kinase du récepteur. Cette activation amorce ensuite de nombreuses
réponses cellulaires via l’interaction de différentes protéines contenant une séquence
homologue aux domaines de liaison 2 de la protéine src (SH2) avec les résidus
tyrosine phosphorylés du site de liaison multi-fonctionnel du domaine C-terminal.
Certains cancers et métastases expriment un c-Met hautement phosphorylé qui se
traduit en un récepteur c-Met plus actif que dans les cellules normales. Pour cette
raison, de nombreuses études effectuées sur c-Met et son implication dans la
formation de tumeur et de métastases consistent à comprendre les mécanismes
pouvant expliquer cette auto-phosphorylation constitutive. Certains groupes de
recherche ont montré la présence de mutations dans le domaine tyrosine kinase de c
Met entraînant tine augmentation de l’activité kinase et l’activation des cascades
dépendantes de cette activation. D’autres groupes font référence à une boucle
autocrine. Ces deux modes d’action peuvent aussi être impliqués simultanément dans
certains cancers dépendant de l’activation de c-Met.
Dans la présente étude, nous avons étudié les caractéristiques tumorales d’une lignée
de cellules invasives (TNV) isolées de cellules MDCK transformées par le virus du
sarcome de Moloney (MSV), les cellules MSV-MDCK-INV, ainsi que le rôle de c
Met dans l’établissement de ce phénotype. Nos résultats démontrent que les cellules
MSV-MDCK-INV ont la capacité de former des foyers indépendants,
lorsqu’ensemencées dans un milieu semi-solide tel que l’agar mou, de la même
grandeur et avec la même efficacité que les cellules tumorales NIH3T3 transformées
par l’oncogère ras (N1H313/ras). Malgré la capacité des cellules MDCK et MSV
MDCK à fonner des foyers dans l’agar mou, la grandeur de ceux-ci et l’efficacité de
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croissance sont négligeables comparé à ce qui est observé pour les cellules MSV
MDCK-INV. Des clones isolés à partir de l’agar mou ont été analysés pour leur
capacité à former des colonies de cellules lorsqu’ensemencées sur une mondcouche
de cellules épithéliales MDCK. Les cellules invasives et les cellules NIH3T3/ras
étaient les seules capables de former des colonies superficielles sur la monocouche de
cellules polarisées. Nous avons aussi montré que les cellules dérivées des colonies
obtenues dans l’agar mou expriment à un degré différent, en relation avec leur
phénotype, certaines protéines impliquées dans les plaques d’adhésion et les contacts
cellules-cellules, telles la kinase présente dans les plaques d’adhésion (FAK), la
paxilline une protéine de structure des plaques d’adhésion et la cadhérine-E une
protéine nécessaire à l’établissement des contacts cellule-cellule. Les cellules CAMI
4, issues de l’une de ces colonies de cellules invasives tirées de l’agar mou, expriment
un c-Met hautement phosphorylé et une capacité d’invasion de 42% supérieure à celle
observée pour les cellules invasives MSV-MDCK-INV. Ces observations suggèrent
un lien direct entre le degré de phosphorylation de c-Met et la capacité motile des
cellules MSV-MDCK-INV, en accord avec certaines observations récentes du
laboratoire.
Les résultats présentés dans ce mémoire montrent pour la première fois que les
cellules MSV-MDCK-INV possèdent des caractéristiques de cellules tumorales.
Malheureusement, aucune mutation n’a été observée dans le domaine tyrosine kinase
ni le domaine C-terminal de c-Met qui pourrait expliqtier le phénotype invasif des
cellules MSV-MDCK-INV ainsi que le phénotype transformé des cellules MSV
MDCK. Ces observations nous portent à croire que la présence d’une boucle
d’activation autocrine du récepteur, via la sécrétion de HGF par ces cellules,
expliquerait le haut degré de phosphorylation de c-Met ainsi que le phénotype
particulier de ces cellules MSV-MDCK-INV. Nous n’excluons cependant pas la
possibilité que d’autres facteurs puissent aussi influencer l’état de phosphorylation de
c-Met dans ces cellules.
Mots clés: HGf-R!c-Met, auto-phosphorylation, invasive, tumeur, agar mou, MDCK,
mutation, domaine tyrosine kinase.
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CHAPTER 1
INTRODUCTION
21.1 Cancer
1.1.1 Definition of cancer and its development
A cancer can be defined as a group of celis among a total population of ceils that
have lost their normal control rnechanisms and thus experience unregulated growth.
Cancer can develop from any tissue or organ and as cancerous ceils grow and
rnultiply, they form a mass of cancerous tissue that invades adjacent tissues and
spreads (metastasizes) throughout the body (Merck Manual, 1997). Cancer ceils
develop from normal celis in a process refened to as transformation. During
transformation, a normal ceil initialÏy experiences a genetic change which primes it to
become cancerous afier exposure to agents referred to as carcinogens. Some
examples of possible carcinogens include chemicals, virus, radiation, or sunlight.
Not ail ceils are equally susceptible to carcinogens. A genetic flaw in the ceil, its
promoter, or even chronic physical irritation may make celis more susceptible to
develop cancer. Changes in a cell’s genetic composition are often hard to detect, but
sometimes a change in the size or shape of one specific chromosome is a good
indication of which type of cancer is involved. Moreover, these genetic changes may
also lead to unscheduled cellular hyperproliferation, either through direct activation
of celi cycle machinery or through signalling pathways that regulate the celi cycle
(Merck Manual, 1997).
1.1.2 Oncogenes and their role in cancer development
Many genes involved in celÏular transformation leading to the development of a
cancerous phenotype have been discovered over the past few years. Cancer ceils may
possess oncogenes, otherwise known as tumour genes, which are involved in the
induction of a cancer. At times, these oncogenes are abnormal versions of the genes
responsible for growth and development before birth, which under normal
circumstances are pemianently deactivated after birth. Their reactivation later in life
may resuit in the development of a cancer. Oncogenes were originally identified in
cancer causing viruses. These viruses may be divided into two groups: the DNA
ttimor viruses that contain either linear or circular double-stranded DNA and the
RNA-containing tumour viruses (also referred to as retroviruses). Stehelin and
3collaborators, while studying the Rous Sarcoma virus (a retrovirus that causes
sarcomas in chickens), were among the first to demonstrate that a viral transforming
gene was derived from a normal cellular gene (Stehelin et al., 1976). Since then,
many other retroviruses have been discovered and shown to contain different
oncogenes derived from and closely related to their cellular counterparts (Bishop,
1985).
The normal cellular genes from which viral oncogenes (v-onc) are derived are
referred to as proto-oncogenes (or c-onc). The way in which proto-oncogenes
incorporate into the viral genome and are converted to viral oncogenes with a high
degree of transforming ability involves the recombination between the retroviral and
cellular genomes. This usually follows the integration of a retrovirus adjacent to a
cellular proto-oncogene in a process known as transduction that is associated with
alterations in the structure and regulation of oncogene sequences (Varmus, 1988).
Figure 1.1 and Figure 1.2 demonstrate how viral RNA, after penetrating the cellular
plasma membrane, is reverse-transcribed to a double-stranded DNA form. Once in
the double-stranded form, it can then proceed to migrating to the nucleus and
integrating itself into the chromosornal DNA.
Retravirus Partiale
EnveIoe RNA
Cap3vi
—
Entry Into celi
and Ioss ot
Reverse envelope
(ranscriptase
Figure 1 .1: Life cycle of a retrovirus. Under normal circumstances a virus contains two
identical RNA strands. For clarity, only one is shown. After penetrating the
plasma membrane, the single-stranded viral ANA genome is reverse
transcribed to a double-stranded DNA form that contains a duplication at its
ends referred to as the long terminal repeat (LTR). The viral DNA then
migrates to the nucleus and integrates into the chromosomal DNA. The
resultant single viral transcript can form the genome for progeny viruses or can
be processed and translated to generate viral structural proteins.
Figure adapted from Tannock and Hill, 7998
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Figure 1.2: Replication and integration of the retroviral genome. RNA s reversed
transcribed to form both linear and circular forms of viral DNA. It is the linear
form of the DNA that integrates into cellular DNA, where t is referred to as a
provirus. Figure adapted from Tannock and Hill, 1998
A large majority of the oncogenes found in transforming retroviruses have also been
identified in spontaneously arising tumors of nonviral origin where they are activated
via other possible mechanisms. Some of these mechanisms are point mutations, gene
amplification, and chromosomal transiocation. The activation of proto-oncogenes is
associated with certain genetic alterations that result in either deregulation of (and an
increase in) expression of the normal gene or alterations in the structure (and
resulting function) of the encoded protein. In fact, ail celis which make up the human
body contain a set of genes that can participate in malignancy following appropriate
activation or deregulation. Proto-oncogenes encode various proteins involved in the
control of ceil proliferation and differentiation, including many growth factors,
growth factor receptors, components involved with signal transduction pathways and
transcription factors that regulate the transcription of mRNA and therefore the
expression of associated genes (Tannock and Hill, 1998).
51.1.3 Tumor suppressor genes and their role in cancer development
Tumor suppressor genes are also regarded as very important players in malignancy.
They are genes that are likcly to play a role in negatively regulating celi growth. The
loss or inactivation of these tumor suppressor genes, as their name implies, is
associated with malignancy (Weinberg, 1991; Knudson, 1993). Tumor suppressor
genes portray different characteristics in comparison to oncogenes. One main
difference is that oncogenes act in a dominant manner and the activating event is
usuaily acquired. Tumor suppressor genes on the other hand act in a recessive
manner. Mutations within a tumor suppressor gene would resuit in its inactivation
and mutated forms of the gene may be inherited. Therefore, turnor suppressor genes
appear very often in the development of familial cancers, but the presence of mutated
forrns of these genes in sporadic cancers is also very common (Tannock and Hill,
1998).
1.1.4 Neoplastic transformation of normal ceils to cancer celts
Neoplastic transformation of human ceils as well as ceils from other species in vitro
is seen as a complex rnultistep process by which normal ceils acquire various
phenotypic abilities. four of these abilities are; the development of morphologicai
transformation, growth in semisolid medium, immortality, and tumorogenicity. A
large majorÏty of human turnor cells of mesenchymal origin do portray morphologicai
transformations that aliow them to grow in conditions in which normal ceils cannot.
In vitro assays used to demonstrate the transformed phenotype of a ccli ail invoive
three main aspects as depicted in Figure 1.3. Initialiy, transformed celis are
examined for their ability to forrn foci. Normal ceils will stop growing when coming
into contact with nearby ceils due to a phenomenon known as contact inhibition.
Transformed ceils are different because they are not contact-inhibited and continue to
grow even when celis corne into contact with one another. In fact, transforrned or
malignant cells grow by piling up over each other and forming bumps over the
monolayer ofcells. These bumps are referred to as foci (Tannock and Hill, 199$).
6Anchorage-independent growth, the ability to grow in a semi-solid medium,
constitutes another very important property of malignant cells (Pavelic et al., 1980).
Normal celis will flot grow unless they adhere to a supporting matrix or suhstrate
such as glass or plastic. By contrast, transformed and malignant celis do flot require
any adhesion or anchorage and are capable of growing when suspended in a
semisolid medium such as soft agar (Tannock and Hill, 199$).
The last and seemingly most influential assay is the tumor formation assay following
injection of tumor celis into nude animais. Normal ceils will flot form tumors when
injected into syngeneic or immunologically deficient animals. Transformed cells on
the other hand do possess this ability (Tannock and Hill, 1998). The phenomena and
rnechanisms involved in induction and progression of a tumor will be discussed later
in this chapter.
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Figure 1 3: Assays of the malignant phenotype. Malignant transformation of a ceil may
be recognized in tissue culture (1) by celis stacking up on the bottom of the
culture dish to form a focus; (2) by growth under anchorage-independent
conditions in semisolid media such soft agar; or (3) by tumor formation in
syngeneic or immune-deprived animais. Adapted from Tannock and Hill, 1998
71.1.5 Tumor progression and classification
Due to the unpredictable nature of cancer, tumors derived from different cancers
display different characteristics. In general, tumors tend to show or become
increasingly malignant with tirne. Some tumors depict an orderly progression from a
benign state to a noninvasive state, followed by the development of pre-malignant
lesions and ultirnately malignancy. Highly malignant tumors on the other hand may
arise de novo, without going through the different stages of progression. Thus, the
degree of progression of any specific tumor is strongly dependent upon the type of
tumor. In terms of classifying the severity of the tumors and deducing whether they
are benign or malignant, it is common practice to assume that tumors that remain
confined to a specific site with well differentiated celis are benign, whereas tumors
composed of poorly differentiated ceils that have spread beyond the local site to seed
metastases are malignant (Tannock and Hill, 1998).
Turnor progression has for a long time been associated with the acquisition of
permanent, irreversible qualitative changes in one or more characteristics of a
neoplasm resulting in the tumor becorning more autonomous and malignant at the
sarne tirne (see Heppner and Miller, 1992; Klein, 1998 for an integrated view).
Recently, rnuch more ernphasis has been placed on genetic changes and how they can
explain what occurs during tumor initiation and progression (NoweIl, 1986). Genetic
changes occur through various rnechanisms, namely point mutation, deletion, gene
amplification, and translocation. A cell’s DNA can be damaged while exposed to
various intracellular and extracellular agents, or through the errors made by
polymerases whenever DNA is being replicated. In normal celis, this DNA damage
is repaired through DNA repair mechanisms found within the ceil or damaged ceils.
Those ceils whose DNA caimot be repaired undergo apoptosis. Unfortunately, these
rnechanisms are flot 100% fool proof and therefore, this leads to a natural frequency
of spontaneous mutations in ceils (Simpson, 1997). In effect, many cancer celis
appear to possess an increased frequency of mutations due to their deficiency in the
repair of DNA lesions and their decreased activation of apoptosis. Therefore, these
$mutated celis forrn a sub-population that can survive and continue proliferating
(Loeb, 199$).
1.1.6 Metastasis
As tumors progress, they acquire the final and most malignant stage, metastasis.
Turnors that have reached this point in their development are usually more difficuit to
treat than those that did not spread and invade other tissues. The cancerous ceils
could spread via the Iymphatic vessels or via the blood vessels. It is for this reason
that clinically, metastases can be divided into two categories: those found in the
regional lymph nodes which have traveled through the lymphatic system, or those in
more distant organs, which have traveled through the body’s blood vascular system
(Taimock and Hill, 199$).
The metastatic process involves four main stcps. First, the metastatic celis must
detach from the primary tumor mass and, depending upon the localization of the
primary tumor mass, the celis will travel or spread via either the lymphatic or venous
system. The inclusion of tumor ceÏÏs into blood vessels may occur as a resuit of a
prior invasion of the tumor mass into the blood vessels or due to the fact that the
vasculature ofsorne tumors may permit passage ofthe ceils into the blood circulation
(Tannock and Hill, 199$). Figure 1.4 depicts an overview of the mechanism by
which tumor celÏs from the primary tumor penetrate the blood vessels to enter the
bloodstream and travel to distant organs to form metastases.
The initial detachment of the primary tumor celis from the primary tumor site is
assumed to involve the decreased expression of adhesion molecules (e.g. cadherins)
that are involved in the “homotypic” adhesion of celis to one another (Birchmeier and
Behrens, 1994).
9The second step in the metastasis process invotves the host’s immunotogic
mechanisms and how they arc evaded during metastasis. There exists evidence in
support of how some human tumors express weaker effects due to the presence of
various cytokines and by nonspecific effector ceils such as natural killer celis (NK
ceils) in the host. These two processes that represent the body’s defense mechanisms
and are in turn inhibited in the presence of a cancer, could reduce the incidence of
metastasis formation (Tannock and Hill, 199$). In effect Hanna, by using
transplanted rodent ceils lias shown an inverse correlation between the activity of NK
ceils in the host animal and the metastatic ability of injected tumor celis (Hanna,
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Figure 1 .4: A model of the major steps of metastasis. Anchorage-independent growth
of epithelial ceils resuits in the formation of a primary carcinoma. The tumor
induces the growth cf blood vessels by angiogenesis. Some tumor celis
separate f rom the primary tumor, invade through the basement membrane,
enter the circulatory system, and eventually arrest in capillaries. At this point,
they extravasate eut cf the blood vessels into the underlying connective tissue
at the metastatic site; there, further ceil growth and angiogenesis resuit in the
formation cf metastatic tumor growth. Angiogenesis is flot seen as being a
crucial step for the invasion and metastasis cf sarcomas due te the fact that
these tumors arise in the stroma in close vicinity to blood vessels.
Adapted from Tannock and Hill, 1998.
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1984). Therefore, a decrease in the number of effective NK celis may play an
important role in the induction and development of metastases.
The third step in the development of a metastasis is rate-limiting and probably the
most critical one. Tumor ceils that have successfully detached from the primary
tumor enter the blood stream where they travel for sorne time before reaching their
destination. In the blood stream, hemodynamic forces eliminate the majority of these
celis and only a small percentage of them survive. It is this small population of tumor
celis that can extravasate successfully and lodge themselves into different organs that
is responsible for the ongoing metastatic process. Before extravasation, tumor ceils
are trapped in the capillaries ofthe lung or liver because they are larger in comparison
to the capillaries. The arrest of tumor ceils within smail blood vessels lias been
associated for quite some time with thrombus formation and involves the interaction
of tumor ceils with platelets and leukocytes. The role of thrornbus formation remains
unclear, but it lias been hypothesized that the adhesive interactions between tumor
ceils and the endothelial ceils lining the capillaries, which occur after the arrest of
tumor ceils, initiate a signal-transduction pathway that promotes the expression of
various genes responsible for the next step of the metastatic process (Tannock and
Hill, 1998).
The step preceeding the arrest of cells in the circulation, as touched upon previously,
involves the escape of cells from the circulation into the host tissue. The first step of
this procedure, outlined in Figure 1.5, involves the extension of tumor celi
pseudopodia into the endothelial celi junctions or the induction of endothelial ccli
retraction that allows access to the basement membrane (Nicolson, 1982). These
pseudopodia are sometimes referred to as invadopodia and contain varying
concentrations of proteases and adhesive molecules that promote the extravasation
and migration process. Direct attachrnent to an exposed portion of the basement
membrane constitutes another route by which tumor ceils may adliere. In fact, the
subendothelial basement membrane is a much better adhesive for tumor celis than is
the endothelial celi surface (Nicolson, 1982). The adhesion of cells to the basement
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membrane involves the binding to certain membrane components such as larninin,
fibronectin, vitronectin, type IV collagen, and proteoglycans (Liotta, 1986; Nicolson,
1988). The binding to these different components is mediated by certain celi-surface
receptors, many of which are members of the integrin family. Following their
adhesion to the basement membrane, tumor ceils then digest the basement membrane
through the use of various proteolytic enzymes which they usually produce or which
they acquire from normal ceils in the vicinity. Once tumor celis have managed to
digest and penetrate the hasement membrane, they can then migrate through it and
escape once again into the interstitial space (Stetier-Stevenson et aÏ., 1993; Mignatti
and Rifldn, 1993; Sloane et aÏ., 1994; MacDougall and Matrisian, 1995).
Aftachment ta endothelial ceils
_
Figure 1.5: Extravasation of a tumor celi. Schematic representation of the processes
involved in extravasation of a tumor celi through the waII of a capillary. The
tumor celi first attaches to the surface al endothelial celis, which cover the
basement membrane. It then attaches itself to the basement membrane
through gaps Ieft between endothelial celis, and using enzymatic digestion,
moves through the basement membrane and into the interstitial space.
Adapted from Tannock and Hill, 1998.
The last step in the progression of a metastasis is to stimulate proliferation among
tumor ceils which have successfuily reached the target organs. One may wonder if
there exists any specificity in terms of which organs are afflicted by the proliferating
tumor ccli. In fact, ceils are known to require certain growth factors for successful
L Retroction ond/or ottachment to
denuded bosement membrane
Enzyme digestion ond movement
through the basement membrane
Escape info the interstitiai space
12
proliferation, and ceilular interactions with the extracellular matrix also play a pivotai
role in proiiferation (Nicolson, 1988; Nicolson and Menter, 1995).
Aside from growth factors that encourage cellular proliferation among tumor ceiis,
there also exist certain factors that inhibit metastasis sucli as TGF-j3, and these factors
also play a role in organ-specific metastasis. In fact, there is evidence which shows
that as tumor ceiis become more malignant, they may switch from being growth
inhibited by TGf-f3 to being stimulated by TGF-E3 (Wright et al., 1993; Lu and
Kerbei, 1994).
Another very important form of evidence that lias been weii documented over time is
the fact that tumor celis do not require exogenous growth factors as cornpared to
normal ceils. Ibis independence is in direct relation with their ability to form tumors
in animais and to metastasize. In many instances, the independence of tumor celis for
exogenous growth factors is reÏated to autocrine production of such factors and the
modification ofthe response to such factors (Taimock and Hill, 1998).
An extremeiy important property pertaining to the growth of a metastasis is the
ability of tumor ceils to induce angiogenesis. This is defined as the deveiopment of
new blood vessels. Folkrnan was arnong the first to dernonstrate that when tumor
fractions were implanted on the comea of the rabbit eye, new blood vessels formed
(folkrnan, 1 976). There exist a number of growth factors such as the basic fibroblast
growth factor (bFGF) (Folkman and Klagsbrun, 1987) and the vascular endothelial
growth factor (VEGf) (Senger et ai., 1983) that are angiogenic and induce
endothelial ceil growth as weii as morphologic differentiation. Without the
development of new blood vessels to supply nutrients to the developing tumor celis,
the tumor would not grow larger than a few miliimeters in diameter.
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1.2 Hepatocyte Growth Factor (HGF)
1.2.1 General aspects ofHGF
The hepatocyte growth factor (HGf), also known as scatter factor, represents a
typical example of how a regular growth factor critical during growth and
development may trigger a change in celÏuÏar phenotype that in sorne instances could
lead to the induction of a cancer. The hepatocyte growth factor is a cytokine that is
ubiquitously expressed by ceils ofmesenchymal origin (Bottaro et al., 1991). In vitro
HGF stimulates celi motility, invasion of surrounding extracellular matrices,
proliferation, survival and morphogenesis, and induces the expression of specific
genes by binding to its receptor, a transmembrane tyrosine kinase encoded by the
MET proto-oncogene in epithelial ceils (Prat et al., 1998).
1.2.1.1 Historical overview ofHGF
Research groups working in the field of liver regeneration and
epithelial/mesenchymal interactions were the first to identify the hepatocyte growth
factor. Initially, HGf was identified as a potent mitogen of hepatocytes in culture.
Studies based on whoÏe animaIs demonstrated the presence of a certain growth factor
found in serum, which mediated rapid regeneration of liver parenchyma in vivo
(Moolten and Buchner, 1967; Fisher et al., 1971). Following these findings,
investigators partially purified this growth factor from the serum of hepatectomized
animais and showed it to be the rnost potent mitogen found in hepatocytes in culture.
This new growth factor displayed characteristics that set it apart from other known
growth factors such as epidermal growth factor, fibroblast growth factor, platelet
derived growth factor, somatomedin, thrombin, and transferin. The newly discovered
polypeptide was named HGF (Mïchalopoulos et al., 1984; Nakamura et ai., 1984).
At approximately the same time that work was being performed on liver regeneration,
a different group of epithelial cell biologists investigating epithelial/mesenchymal
interactions identified a new factor which was found to be produced by fibroblasts
and stimulated movement of cultured epithelial ceils in vitro. This factor derived
from fibroblasts led to the disruption of celi-ceil junctions and Ïed to the scattering of
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islands of non-confluent epithelial ceils in vitro (Stoker and Perryrnan, 1985; Stoker
et al., 1987; Stoker, 1989). It was based upon these findings that the newly fibroblast
derived growth factor was referred to as scatter factor (Sf). Initially, the biological
activities of these two molecules set them as distinct from one another. Subsequent
biochemical analysis and cDNA cloning demonstrated that HGF and Sf represented
the sarne molecule (Nakamura et aï., 1986; Golida et al., 198$; Zarnegar and
Michalopoulos, 1989). Furthermore, these resuits helped classify this growth factor
as a member ofthe Plasminogen Related Growth Factors family (PRGF’s), due to its
structural homology with enzymes of the bÏood-clotting cascade (Stella and
Comoglio, 1999).
1.2.1.2 HGF’s role in different cellular activities
As seen previously, celis of mesenchymal origin are responsible for the production
and release of HGF. The resulting biological activities of HGf are targeted mainly
toward epithelial ceils that express its receptor, the HGF receptor otherwise known as
c-Met. from this specific interaction existing between both ceil types, the HGF was
c]assified as a paracrine mediator in the interaction that exists between mesenchymal
and epithelial ce]ls in vivo (Stoker et aï., 1987; Birchrneier and Birchmeier, 1993).
Epithetial celis, as targets of HGF, are thought to influence the production of HGF by
mesenchymal ceils in a paracrine fashion (Joseph et aÏ., 1995; Rosen et aÏ., 1994).
The factors of epithelial nature, responsible for the stimulation of mesenchymal HGF
production have not been well defined at this time. It is however known that HGF
expression by fibroblasts is inhibited by several known peptide growth factors, such
as transforming growth factor beta, epidermal growth factor, and transforming growth
factor alpha (Seslar et al., 1993).
HGF/SF, in vivo, plays a role in the neural system (Streit et al., 1995; Ebens et ctl.,
1996), kidney (Santos et al., 1994; Wolf et al., 1995) and marnmary gland (Niranjan
et al., 1995; Soriano et aï., 1995; Yang et al., 1995) development, tissue regeneration
(Matsumoto and Nakarnura, 1993), angiogenesis (Bussolino et al., 1992), turnor
invasion and metastasis (Giordano et al., 1993; Rong et aï., 1994). HGF is also very
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important during embryogenesis where its signailing is essential for liver and
placenta development (Schmidt et al., 1995; Uehara et aÏ., 1995) as well as for
migration ofmyoblast precursors from the limb buds (Biadt et al., 1995; Maina et al.,
1996). In addition, this growth factor is involved flot only in the stimulation of
hepatocytes, but also of other primary cuhured celis, including melanocytes and renal
tubular ceils (Igawa et al., 1991; Kan et al., 1991; Matsumoto et aÏ., 1991; Rubin et
al., 1991). Furthermore, serum HGF levels have been found to be elevated in
patients suffering from chronic hepatitis and liver cirrhosis (Tomiya et aÏ., 1992) and
in animais being treated with a hepato-promoter (Lindroos et al., 1992).
1.2.1.3 StructuraI characteristics ofHGf and its activation
In terms of its structural characteristics, the hepatocyte growth factor (HGF) is a
heterodimeric protein containing a cx chain composed of an N-terminal hairpin loop
and four kringle domains, as weii as a serine protease-like f3-chain (Stoker et aï.,
1987; Mizuno and Nakamura, 1993; Nakarnura, 1991). It is synthesized and secreted
as a biologicaily inactive single-chain 92 kDa precursor, which is converted into the
bio-active dimer in the extracellular environment either by serine proteases activated
during the coagulation process (Miyazawa et al., 1994), or by the urokinase type
plasminogen activator (uPA) bound to its receptor (uPA-R) at the ceil surface
(Naldini et al., 1992). Figure 1.6 illustrates how HGF goes from its inactive state
where the cx and [3 chains are attached, to its active mature form where it is cleaved
and the resulting cx and [3-chains are attached via a disulphide bond. Moreover,
stimulation by HGF induces the expression of both uPA and its receptor (Boccaccio
et al., 1994; Pepper et al., 1992). UPA is also a very important component for its
ability to catalyze extraceliular matrix degradation (Blasi, 1993). Therefore, the
activity generated by the coupiing of the HGF/HGF-R and uPA!uPA-R pairs is
directly invoÏved in ccli associated proteolytic processes required for tissue
remodelling, celI migration and celi invasion during wound healing, angiogenesis and
tumor metastasis (Blasi, 1993).
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1.2.1.4 HGF’s foie iii celi scattering
HGf/SF’s role in ceil migration involves the initial recruiting of integrin receptors
found on the ceil surface and in contact with the extracellular matrix, cytoskeletal
proteins, and 125FAK into focal adhesions that are strongly dependent on tyrosine
kinase activity (Matsurnoto et aÏ.1994). Unlike the growth factor receptors, integrin
receptors lack intrinsic tyrosine kinase activity. It is for this reason that one of the
initial steps during integrin signalling is the tyrosine phosphorylation of the non
receptor tyrosine kinase, focal adhesion kinase (FAK), in response to ceil adhesion
(Schaller et aÏ., 1994; Richardson and Parsons, 1995; Parsons 1996; Chandra Kurnar,
199$). AlI 13t and Œ containing integrins share the ability to promote the assembly of
focal adhesions and activate FAK. FAK is a non-receptor tyrosine kinase absent of
any src homology (SH)2 and SH3 domains, and its phosphorylation is believed to
resuit in the activation of a cascade of phosphorylation events and new protein
interactions which are essential for adhesion-dependent signalling complexes (Figure
1.7).
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Figure 1.6: Structure of HGF/SF. HGF/scatter factor in its pre-form where both X and 3-
chains are attached and in its active form where it is cleaved and the Œ-chain is
attached to the 13-chain via disuiphide bond (a). The a-subunit of HGF contains
one hairpin Ioop and four kringle domains depicted in red that are triple-Iooped
cysteine-rich motives involved in protein-protein interactions (b).
Figure adapted from Nakamura etat, 1989.
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FIGURE 17: Integrin and growth-factor signalling through paxillin, and interactions
with the actin cytoskeleton. A) Paxillin is involved with the recruitment of
varfous signalling proteins to the plasma membrane, including the tyrosine
kinases FAK and Src. The activation of these proteins is achieved through
the interaction of integrins with the extracellular matrix, or after growth factor
stimulation of receptor tyrosine kinases (RTK). The complex of proteins leads
to the activation of the mitogen-activated protein kinase (MAPK) cascades,
thereby stimulating gene expression. The signalling and cross-talk with
integrins that is mediated by growth factor signalling, is enhanced by
paxillins ability to bind a PKL-PIX-PAK-Nck complex. B) Paxillin is seen
bound to various proteins that help in the organization of the actin
cytoskeleton at contact sites between integrin receptors and the extracellular
matrix (focal adhesion points). Vinculin and actopaxin physically bind paxillin
to actin filaments. The binding of the adaptor protein Crk to paxillin, which is
phosphorylation-dependent, is necessary for the regulation of celI motility in
certain ceIl types. Microtubule binding to paxillin also contributes somewhat
to the ability of this filament system to promote celI motility via the disruption
of focal adhesions. Figure reproduced from Turner, 2000.
Talin for one, is a protein that binds directly to the carboxy-terrninal domain of fAK
tAAP kinaso superr1y avar
PrsiHera,on
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(Chen et aÏ., 1995) and also interacts with vinculin and subsequently paxillin (Brown
1$
et cii., 1996). Paxillin in turn binds to a distinct site in the carboxy terminus of FAK
(Schaller et ai., 1995). Therefore, there is evidence to believe that the recruitment of
fAK to activated integrins is an indirect process mediated by talin, and that once
fAK lias been recruited to the focal adhesion complexes, it undergoes a
conformational change and interacts through its amino terminal dornain with the 3
subunit tau (Richardson and Parsons, 1996). This conformational transition is
therefore a prerequisite for FAK’s catalytic activity because it leads to a trans
autophosphorylation on residue 397 which in turn resuits in the interaction with Src
and Fyn through their SH2 domain (Schaller et aÏ., 1994). Src and Fyn are then
responsible for the pliosphorylation of a number of FAK-associated proteins
including paxillin and tensin (Vuori et aï., 1996; Schlaepfer and Hunter, 1997;
Schlaepfer et ai., 1997). Once in the phosphorylated state, FAK can then combine
with and activate Pl3Kinase (Chen et aÏ., 1996). Hence, FAK is associated with
various intracellular signalling pathways, namely those involved with cell adhesion
and cell motility. Embryonïc fibroblasts derived from FAK knockout mice have
shown to form numerous small focal contacts, but were unsuccessful in forming large
peripheral focal adhesions and were found to migrate less efficiently than control
celis (hic et ai., 1995). Another piece of evidence supporting FAK’s role in cell
migration is that overexpression of FAK stimulates cell migration. A dominant
negative forrn of FAK completefy inhibits celi migration (Cary et ai., 1996; Gilmore
and Romer, 1996). These observations are contradicted by the report of Matsumoto
and colleagues (Matsumoto et ai., 1994). He states, with regards to FAK, that a
“GraduaI loss of tyrosine phosphorylation coincided with dismption of focal
adhesions and conversion to a motile phenotype”. He also goes on to propose that
“HGF/SF-induced phosphorylation of pl25’ may actually indicate the disassernbly
of the focal adhesions, a process apparently required to ceil mobilization and
locomotion” (Matsumoto et cii., 1994). Therefore, it would seern that according to
Matsumoto, FAK would be over-expressed in motile ceils, but phosphorylation on
FAK would be greatly diminished.
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The presence of HGF bound to its tyrosine kinase receptor (RTK) as seen in Figure
1.7, is essential in triggering the aforementioned cascade leading to ceil scattering.
Recruitment of integrin receptors on the ce!! surface as well as activation of different
proteins invo!ved with cellular rnotility and scattering is strongly dependent upon the
tyrosine kinase activity produced when HGF activates HGF-R (c-Met). It is for this
reason that the expression of certain proteins such as FAK and paxillin are examined
extensive!y when working with invasive or motile ccli unes.
1.2.2 Receptor tyrosine kinases and their role in ccli growth
The process of ccli growth and differentiation is triggered when extracellular
substrates are recognized at the ce!! surface by a receptor, resuiting in the activation
of associated cytop!asrnic and nuclear biochemical cascades. When deregulated,
these normal growth-signalling pathways may be key to the maÏignant transformation
of human ce!ls. Growth factors were initia!!y identified from culture medium for
their abi!ity to independent!y sustain ce!l growth. Viraily transformed cel!s, unlike
normal ceiis, depict !ower requirernents for exogenous growth factors. With the
exception ofTGf-3, which stimulates the proliferation ofvarious mesenchymal ceils,
inhibits the proliferation of many epithe!ia! cells and binds to a receptor with serine
threonine kinase activity (Derynck, 1994). most growth factors bind to specific
transmembrane receptors beionging to the family of receptor tyrosine kinases
(RTK’s). These RTK’s have been invo!ved with human diseases such as
deve!opmental disorders and even cancer. Signal transduction by this fami!y of
RTK’s is achieved through a series of steps including: a) ligand binding to the
receptor and subsequent receptor dimerization, b) receptor trans autophosphory!ation
on tyrosine residues, c) recruitment to the receptor’s cytoplasmic tau and activation
of cytoplasmic signaliing molecules that are mediators in the transmission of
information to the nucleus (Longati et aï., 2001).
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1.2.2.1 Historïcal overview of the hepatocyte growth factor (HGF-R)
HGF induced invasive growth is mediated by the HGF-R, or Met receptor. The
HGF-R was identified as the c-met proto-oncogene (Bottaro et aÏ., 1991) and
originally isolated as a transforming gene from a human osteogenic sarcoma ce!! !ine
(HOS) that was treated in vitro with the chemical carcinogen N-methyl-N’-nitro-N
nitrosguanidine (MNNG) (Blair et al., 1982; Cooper et aÏ., 1984). Its activation in
these HOS ce!!s occurred via a DNA rearrangement that resulted in the fusion of
sequences from the TPR (trans!ocated promoter region) !ocus on chromosome 1 to
sequences from the met !ocus on chromosome 7 (Park et al., 1986; Dean et ai., 1987).
Activation of the met oncogene via DNA rearrangement and fusion resemb!es to a
great extent the activation process for several members of the tyrosine kinase family
of oncogenes.
Nucleotide sequencing of a portion of the met oncogene showed that it was in fact a
member of the tyrosine kinase fami!y of oncogenes. It resembles to various degrees
the roii and sea oncogenes, and its kinase domain is most homologous to the human
insu!in receptor (HIR) (Ulrich et al., 1985) and the murine v-abl oncogene (Reddy et
al., 1983). Overexpression of the met proto-oncogene is evident in tumors of specific
histotypes inc!uding thyroid (DiRenzo et ai., 1992), pancreatic carcinomas (DiRenzo
et aÏ., 1995), and in hereditary papiiiary renai carcinomas (HPRC) (Schmidt et al.,
1997).
1.2.2.2 Structural characteristics of HGF-R
HGF-R is a heterodimer of 190 kDa comprising an Œ-chain of 50 kDa containing the
HGF binding site. The Œ-chain is heavily glycosylated, found on the ccli surface, and
which is linked via a disu!phide bond to a 13-chain. The 145 kDa f3-chain contains the
kinase domain with the tyrosine autophosphory!ation sites and the multifunctional
docking site that comprises a specific stretch of amino acids located in the carboxy
terminal of the protein (Comog!io and Vigna, 1995). C-Met is synthesized as a
giycosy!ated single chain precursor that undergoes proteolytic processing to form a
mature heterodimer (Giordano et al., 1989a).
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The Met cytoplasmic domain can be divided into three distinct and functional
domains as depicted in Figure 1.8(A).
Figure 1.8:
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Structure of the HGF Receptor. A) Representation of the HGF/c-Met
receptor. The receptor comprises an extraceliular transmembrane Œ-chain
that forms the docking area for HGF. The f3-subunit contains three domains;
the juxtamembrane domain, the catalytic domain and the C-terminai domain
ail containing tyrosine residues which when phosphoryiated, are involved
with HGF-Rs enzymatic activity and hence ceilular responses. B) The C-
terminai domain contains a two-tyrosine multi-functional docking site which
when phosphorylated (following activation by HGF), binds different SH2-
containing factors involved with cellular responses such as celi motility.
Figure 8(A) adapted from Bardelli etat, 1997
Figure 8(B) adapted from Furge et al., 2000
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The juxtamembrane domain, which immediately follows the transmembrane domain,
negatively regulates Met activity. The phosphorylation of a serine in this domain,
serine 975, by Protein Kinase C (PKC) or Ca27 Calmodulin-dependent kinase, andlor
the recruitment of a cytoplasmic tyrosine phosphatase by the phosphorylated tyrosine
1003, inhibit the Met kinase activity (Gandino et aï., 1990; Gandino et al., 1994;
Vilia-Moruzzi et al., 1993). Phosphorylation of two tyrosine residues in the kinase
domain ofthe receptor (Y1234 and Y’235) positively regulates the enzymatic activity of
the Met kinase domain (Ferracini et al., 1991; Longati et aÏ., 1994; Naldini et aï.,
1991). This increased c-Met activity can promote the metastatic spread of cancer due
to its stimulatory effects on a variety of processes such as angiogenesis, cellular
motiiity, and protease secretion (Jeffers et al., 1996). The C-terminal domain also
contains a two-tyrosine region (Y’349 and Y1356) that is refened to as the multi
functional docking site. Once both tyrosines become phosphorylated, this docking
site, as depicted in Figure 1.8(B), binds multiple SH2-containing transducers,
including p85 the catalytic subunit of the phosphatidylinositol 3-kinase (P13-kinase)
(Graziani et al., 1991), phospholipase C-y, Src, the adaptors Grb2 (Growth factor
receptor-bound protein 2) (Ponzetto et al., 1994) and SHC (Pelicci et al., 1995), the
transcriptionai factor STAT-3 (Signal transducers and activators of transcription-3)
(Boccaccio et al., 1998), and the docking protein Gabl (Grb-2 associated binder 1)
(Weidner et al., 1996). This muiti-functional docking site is crucial for ail Met
mediated responses. Substitution of both tyrosines (Y’349 and Y’356) with
phenyialanine resulted in the abolishrnent of Met-mediated responses both in vitro
and in vivo (Maina et al., 1996; Ponzetto et aÏ., 1994).
A study by Guai and collaborators bas recentiy demonstrated that the last 26 amino
acids in the C-terminal domain positively regulate Met kinase activity and that their
presence is critical for the transforming abiiity but not for Met-mediated invasiveness
(Guai et ctl., 2001). By constructing mutants that contained various deletions of the
C-terminal domain and transfecting these mutants into NIH3T3 ceils, they were able
to establish that deletion ofthe last 47 arnino acids in the C-terminal domain (the A47
mutant) displayed a lower level ofphosphorylation. This was easiiy explained by the
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fact that Met M? lacks three auto-phosphorylation sites (Y’349, Y’356 and Y’365) (Guai
et aÏ., 2001).
Following these findings, they proceeded to look at the enzymatic activity of the
various mutants in comparison to the wild type Met. With the use of an exogenous
substrate, the myelin basic protein (MBP), they measured the phoshorylating ability
of the different receptors. The deletion of the last 47 amino acids resulted in a 46%
increase in Met’s ability to phosphorylate MBP in vitro as compared to the wild type.
Thus, from these resuits it seems that this domain negatively regulates Met’s
enzymatic activity. In agreement to this, work from Bardelli and collaborators
showed that a celi-permeable peptide derived from the Met tau (Ile-Gly-Glu-His
Tyr’ 349-Val-His-Val-Asn-Ala-Thr-Tyr’ 356-Vai-Asn-Val-Lys-Cys-Val-Ala) and
containing the docking site inhibits receptor activity. Once internalized with the heip
of the Antennapedia internalization domain at the amino terminus, the tau peptide
blocked both ligand-dependent autophosphorylation and downstream Met signalling.
One possible explanation for this inhibition as presented by Bardelli and his
collaborators, us that the Met tau could impair receptor phosphorylation by interacting
with another moiety of the catalytic domain. (Bardelli et aÏ.,1999). The A26 mutant
was also of extreme interest. The deletion of the last 26 amino acids resulted in a
35% reduction in Met’s ability to phosphorylate MBP, compared to the wild type.
These findings indicate that this portion of the receptor tail positively regulates the
tyrosine kinase activity. Altogether, the findings by Guai and lis collaborators
propose that the C-terminal domain of Met contains two regulatory regions
displaying opposite effects on the receptor kinase activity.
In a study from Giordano and collaborators, Met-mediated transformation was
examined in NIH3T3 fibroblasts transfected with the full-length met cDNA
(Giordano et aÏ., 1993). Exposing these transfectants to HGF resuited in a
stimulation of tyrosine kinase activity and induced changes in cell shape, migration in
Boyden chambers, and invasion of collagen matrices in vitro. In addition to these
findings, it was observed that their motile and invasive phenotypes were soiely
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dependent upon the presence of the HGF/SF and that the factor promoted colony
formation in soft agar in the presence of 5% calfserum.
Due to its seemingly influential role in cellular invasion and motility during early
development, the possible role of c-Met in certain cellular transformations or even in
certain cancers was exarnined. In fact, rnany research projects in the field of cancer
research today aim to assess the peculiar ability of malignant tumor ceils to escape
from the primary tumor and settie at distant organ sites. The HGFRhnet gene is
physiologically expressed in many celi types, especially of epithelial nature (Tajima
et al., 1992), and is frequently over-expressed in many types of cancer.
1.3 Mutations in the met gene and their role in carcinoma development.
1.3.1 Met mutants in papillary renal carcinomas (PRC)
The identification of germ-line and sornatic mutations in the Met gene in papillary
renal carcinomas (Schmidt et al., 1997; Schrnidt et al., 1999) and chuldhood
hepatocellular carcinornas (Park WS et al., 1999) bas established the connection
between Met and human cancers. AÏ! of the mutations found to date are located
within the tyrosine kinase domain, either in the N-terminal portion, which contains
the ATP binding site, or in the C-terminal portion, which includes both the catalytic
and activation loops. Studies have demonstrated that ail mutations reported so far
seem to activate the catalytic activity of the receptor at different degrees (Jeffers et
al., 1997; Bardelli et aÏ., 1998; Giordano et cii., 2000). Moreover, Jeffers and his
collaborators illustrate that different Met mutations identified in both bereditary and
sporadic cases of human papillary renal carcinomas resuÏted in different levels of
enzymatic activity in c-Met whicb translated into different levels of tumorigenicity
(Jeffers et al., 1997).
By stably transfecting NIH3T3 celis with some Met mutants, Jeffers and bis team
observed higher levels of Met phosphorylation among certain mutants and lower
levels among others (Jeffers et cii., 1997) (Table 1.1). In order to quantify the in vitro
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transforming ability of the mutants, they performed a focus-formation assay among
ail mutants. Their resuits demonstrated that the most active mutants (i.e M1268T,
Y124$H, D1246H, D1246N and Y1248C) produced a higher number of foci per jig
of DNA when compared to their less active counterparts that failed to produce any
foci. Tumor formation in athymic mice is an additional assay which demonstrates the
functional consequences of c-Met mutations. The results obtained illustrate that ceils
expressing each of the mutant Met proteins form tumors, and that ceils expressing the
wiid type protein failed to produce foci in soft agar as well as tumors in mice. As
was observed with the focus—formation assay, a strong correiation exists between the
Met mutants’ enzymatic activity and their resulting turnorigenicity. Therefore, from
the gathered resuits, it is evident that the M1268T mutation found in the tyrosine
kinase domain of c-Met among this and other cancers, remains one of the most
influential and important mutation.
Table 1. Activitv of Met mutants
Tumoi formation
Met Focus # mice with
plios- formation tumors/# mice Mean turnor
Met construct* phoryIation #foci/ig DNA injected size, mm
— Wild type — O 0/14v 01
M1268T(s) +++ >300 8/8 216 ± 77
Y1248H() ++ 156 ± 16 8/8 lOt) ± 40
D1246H(s) ++ t19 ± 16 8/8 60 ± 52
D1246N(g) ++ 147±5 9/9 50±25
Y1248C(g) ++ 115 ± Il 7/8 77 ± 89
V12381(g) ++ 0 5/8 3 ± 15
V1206L(g) + 0 6/6 50 ± 32
M1149T(g) - + 0 4/8 46 ± 56
Table 7.1: Activity of Met mutations when transfected in NIH3T3 ceils.
Table reproduced from Jeffers et al., 7997
Other research groups sucli as that of Giordano and collaborators revealed the
presence of mutations in the c-Met of papillary renal carcinomas (PRC) different
from those analyzed by Jeffers and collaborators (Jeffers et aI., 1997). Giordano and
her team also demonstrated the presence of mutations within the tyrosine kinase
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domain of c-Met (Figure 1.9(A)) which supports the fact that mutation M1250T
displays the highest transforming ability in relation to the focus formation assay
(Figure 1.9(B) bottom portion) as well as the highest mitogen activity as measured
by a luciferase activity assay (Figure 1.9(B) top portion) (Giordano et al., 2000).
Figure 1.10(A) illustrates the precise localization of these mutations within the
kinase domain of c-Met and the hornology with residues rnutated in the RET and KIT
receptors. Both RET and KIT receptors are members of the receptor tyrosine kinase
family (RTK). Ail members in this family of receptors prornote invasive growth
signaling through their own distinct version of a docking site (Bardelli et al. 1997).
Results obtained from their study illustrate that mutations that alter residues located
in both the activation loop and in the N-terminus of the kinase domain are efficient
enough at transforming mouse flbroblasts (Giordano et al., 2000). An example ofthis
can be found in Figure 1.9(B), where it is clear that the MetLl 195V mutation found
in the N-terminus of c-Met’s kinase dornain expresses the same trancriptional activity
and produces the same number of foci as for instance, the MetYÏ23OC mutation
found in the activation ioop.
The Met receptor as seen previously, is expressed in epithelial celis and elicits
various biological responses such as ccli proliferation, protection against apoptosis,
and invasion of the surrounding extraceÏÏular matrices. In order to examine the effect
of some PRC mutations on these different biological properties, Giordano and ber
team transfected human Met DNA containing the various mutations into MLP 29
murine celis which display many biological properties in response to HGf treatment
(Medico et cii., 1996). The celis having been successfully transfected with the PRC
mutations displayed a “scattered” phenotype consisting of the graduai disassembling
of tightly packed islands typical of epithelial ceils. The introduction of exogenous
HGF to these celis resulted in a higher degree of “scattering” in ceils expressing the
PRC mutants as opposed to ceils expressing normal human Met (Giordano et al.,
2000).
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Figure 7.9: Localization of Met mutations found in papillary renal carcinomas (PRC)
and their respective activity. A) Illustration of Met mutations found in
papillary renal carcinomas (PRC). Blue boxes represent the tyrosine kinase
domain (KD), which can be divided into N- and carboxyl-terminal lobes (N-L
and C-L respectively) separated by a large ioop referred to as the activation
loop (AL). B) Upper portion: Transcriptional activity of Met mutants transfected
in NIH3T3 celis in the presence (dashed bars) or the absence (open bars) of a
dominant negative Ras (Nl7Ras). Lower portion: Transforming ability ot
MET° mutants evaluated using the focus tormation assay with MLP 29
murine epithelial liver oval cells harbouring different PRC mutations.
Adapted from Giordano et al., 2000
1.3.2 PRC Met mutants and tubulogenesis
In addition to the characteristic scattering behaviour, ceils transfected with PRC
A
Y
Y
B
mutants, when stimulated with exogenous HGF, migrate in three-dimensional
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collagen gels and form long and branched tubules (Khwaja et aL. 1998,). When HGf
is rernoved from the ceils’ environment, celis develop cystic structures with spikes
projecting outwards. This was not observed among normal non-transfected ceils. To
further assess the capacity of these celis to display an invasive phenotype, Giordano
and ber team tested their ability to invade reconstituted basement membrane
(Matrigel®) in vitro. According to previous studies, Pl3Kinase plays a pivotai role in
cellular invasion and tubulogenesis (Kliwaja et ut., 1998). for this reason, the
interaction existing between the various PRC Met mutants and the p85 subunit of
Pl3Kinase was elucidated. PulÏ-down experiments of the Met’ mutants with the
GST protein fused to the SH2 domain of the amino-terminal in p85 illustrated that
mutants expressing the better invasive and tubulogenic ability (i.e. MetLl 195V and
MetYÏ23OC) interact efficientÏy with Pl3Kinase, whereas the mutants with decreased
invasive and morphogenic ability (i.e. MetMI25OT and MetDl228H) interact at a
lower level with Pl3Kinase. An imbalance between the activation of the Ras and
PBKinase pathways couid explain this variation among mutants due to the fact that
activation of the Ras pathway resuits in disorganized growth that translates into
reduced invasion and tubulogenesis (Khwaja et aÏ., 1998).
1.3.3 PRC Met mutants and apoptosis inhibition
The appropriate progression of a turnor is also very dependent upon the inhibition of
apoptosis. Cells expressing the PRC Met mutations were exposed to staurosporin
(apoptosis-inducing drug) to analyze the mutant response during apoptosis. Ceils
expressing mutants MetLl 195V and MetY123OC were found to be more resistant to
apoptosis and this resistance was further enhanced by applying exogenous HGf
(Figure 1.10). Therefore, the resuits presented by Giordano and collaborators
dernonstrate that mutants with a Ïow transformation potential in vitro and a strong
invasive and tubulogenic potential, are more resistant to apoptosis.
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In fact, HGF1Met plays an important role in apoptosis. Experirnents performed on
SK-LMS-1 leiomyosarcoma celis, demonstrate that the Akt kinase (kinase that
protects celis from apoptosis) is activated by HGF in a time- and dose-dependent
mariner by Pl3Kinase (Xiao et aÏ., 2001). Akt is also activated by tumorigenic forms
of Met, truncated and constitutively dirnerized forms of Met, and mutationally
activated versions of Met corresponding to what is found in human hereditary
papillary renal carcinornas. furthermore, in NIH3T3 celis transfected with wild type
Met, HGF was found to inhibit apoptosis induced by serum starvation and UV
radiation (Xiao et cil., 2001). Thus, there is strong evidence that HGf could inhibit
celi death through the Pi3-kinase/Akt signalling pathway.
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Figure 1.10: MetPRC mutants and their typical anchorage-independent growth and
protection from apoptosis. Stable transfectants with Met mutants, and their
ability to form colonies in soft agar either in the presence (blue bars) or the
absence (red bars) of Baculovirus-produced human HGF.
Figure adapted from Giordano etat, 2000
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1.3.4 PRC 1’Iet mutants and anchorage-independent growth
Another very important aspect of Met PRC mutant-transformed ceils was their
capacity to grow in an anchorage-independent environment. As seen earlier, this
aspect of malignant growth remains one of its most important features. Thus, cells
expressing the normal Met receptor formed very small colonies both in the presence
and the absence of HGF. Cells expressing PRC Met mutants on the other hand
formed numerous large colonies in the presence of HGF thus illustrating their
capacity to grow in an anchorage-independent environment (Giordano et aL, 2000).
1.4 The Madin Darby Canine Kidney (MDCK) Cett Line
1.4.1 Historical Overview
The Madin Darby Canine Kidney CeIl line (MDCK) was originally derived from
normal dog kidney in 195$ and used in virology studies (Gausch et al., 1966). The
cells were then used as a model for studying the function of epithelial ceils and more
importantly, to investigate epithelial celI polarity (Mostov and Deitcher, 1986). In
culture, these MDCK cells form a polarized sheet one cell thick with many of the
properties that are normally found in canine kidney epithelium from which it is
derived. When grown on porous filters, these ceils have the ability to form a well
polarized monolayer and reconstitute a simple epithelial tissue with distinct apical
and basolateral surface domains (Sirnons and Fuller, 1985). Like normal epithelial
celis, MDCK cells form tight junctions that allow the epithelial sheet to function as a
selective permeability barrier between the outside environment (above the cell
monolayer) and the tissue compartments (under the ceil monolayer). It is this
permeability barrier that is responsible for the vectorial transfer from the external
medium to the celi cornpartment.
1.4.2 The MDCK ceil une and c-Met
Response from the MDCK ceil line to HGF activation of c-Met is strongly dependent
upon culture conditions and involves morphogenic and motogenic changes. These
responses include ceil scattering (Stoker et ai., 1987), tubulogenesis in collagen
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(Montesano et aï., 1991a), and dedifferentiation of polarized celis grown on
permeable filter supports (Balkovetz et aÏ., 1997). The HGF receptor is selectively
located on the basolateral plasma membrane domain of polarized epithelial cells by
direct delivery from the trans-Golgi network after synthesis (Niranjan et al., 1995).
The localization of c-Met at the basolateral membrane supports the role of HGF as an
important mediator in epithelial/mesenchymal celi interactions.
The scattering of MDCK celis appears to occur in two distinct stages. In the first
stage, the celis diverge away from each other while still maintaining contact points
between each other. In the second stage, the ceils separate completely and move away
from one another. MDCK ceil scattering in response to HGF was shown to resuit
from cytoskeletal reorganization (membrane niffling and larnellipodium extension,
disappearance of peripheral actin bundies at the edge of colonies, and an overali
decrease in stress fibers), the loss of intercellularjunctions, and ceil migration (Ridley
et al., 1995). Recent findings suggest that certain members of the Ras family of GTP
binding proteins may play a role in cellular movernent. In fact, the Rac and Rho
proteins have shown the ability to regulate actin reorganization in Swiss 3T3
fibroblasts in response to certain extracellular factors (Ridley and Hall, 1992; Ridley,
1994). Moreover, a microinjection of Ras, Rac, and Rho proteins and dominant
negative mutants of the aforementioned poteins showed that HGF-induced movement
requires activation of both Ras and Rac, whereas movement is inhibited when there is
an increase in the Rho protein. Therefore, celi movements via changes in actin
polymerization are a resuit of a downstream interaction or signalling process between
Ras, Rac, Rho and c-Met (Figure 1.8(B)).
1.4.3 HGF and c-Met’s role in MDCK ceil tubulogenesis
Tubulogenesis is also a process essential for the proper development of various
epithelial organs such as the kidney, intestine, pancreas, liver, and lung. Montesano
and lis group established the first in vitro model for epithelial cell movement in
which tubular structures were formed (Montesano et al., 1991a). In this study, they
observed the development of tubular structures from cysts composed of MDCK celis
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that were exposed to conditioned medium derived from MRC-5 human embryonic
lung fibrobÏasts or otherwise known as NIH3T3 fibroblasts. In normal conditions
where MDCK celis are flot treated with conditioned medium derived ftom fibrbblasts,
they forrn hollow spherical cysts with no apparent tubular structures. Montesano, by
flrst applying exogenous HGF and then cornpletely eliminating the response by
adding antibodies against HGF (Montesano et al., 199 lb), later dernonstrated that it
was in fact HGF which triggered this branching tubulogenesis from these ceils in
collagen. Due to the activation by c-Met’s tyrosine kinase activity by HGf,
tubulogenesis induced by HGF lias been shown to be a phosphorylation-dependent
process in MDCK ceils (Santos et al., 1993). Santos and others in the field
demonstrated that HGF-induced tubulogenesis can also be modulated by other
mechanisrns involving phosphorylation and including protein kinase C (PKC),
protein kinase A (PKA), and Ca2/ calmodulin (CaM)-dependent kinases. For
example, more complex tubular structures have been observed when PKC was
inhibited compared to what was observed with HGF activation alone. By contrast
activation of PKA with a subsequent inhibition of calmodulin led to a decrease in
tubule formation in the presence of HGf. Thus, based on these observations, it would
be plausible to state that c-Met activation initiates epithelial tubulogenesis that can be
subsequently rnodulated by PKC and/or PKA kinases as weÏl as calmodulin (CaM)
and CaM-dependent kinases. In addition to these modulators, extracellular matrix
(ECM) proteins are also involved with, and regulate the formation of HGF-induced
MDCK celI branching tubular structures (Santos and Nigam, 1993). Among these
ECM proteins, laminin, entactin, and fibronectin induced the formation of tubules and
increased their branching complexity. In contrast, ECM proteins such as type IV
collagen, heparin sulfate proteoglycan, and vitronectin, substantially inhibited tubular
formation. Interestingly, the opposing effects of fibronectin and vitronectin observed
in the HGF-induced tubulogenesis parallels what is observed in HGF-induced MDCK
celi scattering (Clark. 1994). Ibis aspect assumes a very important role for these
ECM receptor proteins, such as fibronectin, on processes involving epithelial celi
movement.
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Movement between epithelial cells also requires to some extent the regulation of ccli
ceil adhesion proteins. t3-actin, for instance, was originally identified as a factor
playing a rote in cadherin mediated celi-celi adhesion junctions (Nagafuchi and
Takeichi, 1989) and is involved with morphogenesis during embryonic development
(McCrea et aL. 1993; Larabeil et ai., 1997). J3-catenin not only binds to E-cadherin
but also to the adenomatous polyposis cou (APC) protein (Hulsken et aÏ., 1994)
which is a cytoplasmic protein and the product of a tumor suppressor gene that was
found to be mutated in colon cancer (Rubinfeld et al., 1993). A study from Pollack
and collaborators pcrforrned with the MDCK tubulogenesis model, iilustrated that the
interaction of f3-catenin with the APC protein is essential for one of the very eariy
steps in the initiation of tubule formation (Pollack et al., 1997). Their observations
dernonstrated that flot only is 3-catenin involved with the formation of celi-ceil
adherens junctions, it also plays a role in ceil migration during tubulogenesis through
interactions with the APC protein. In fact, when the J3-catenin protein is mutated to
block interaction with the APC protein, ceil migration, which is observed during
tubulogenesis, is inhibited.
A more recent study lias demonstrated that HGF-induced tubulogenesis in MDCK
ceils is also dependent on the transcriptional factor STAT-3. STAT proteins are
phosphorylated by Jak kinases in the cytoplasrn on tyrosine residues (Boccaccio et
ai., 1998). This phosphorylation leads to STAT-3 protein dimerization and
transiocation into the nucleus where they express their function as transcription
factors by binding to specific promoter sequences (Ihle, 1996). It is the binding of
HGF to its c-Met receptor that leads to the recruitment of STAT-3 to the
multifttnctional docking site in the C-terminal domain, subsequent phosphorylation
on STAT-3 tyrosine residues, nuclear translocation, and binding to its specific
promoter elernent. The introduction of a tyrosine phosphorylated peptide, which
interferes with the association between STAT and the receptor, as well as STAT
dimerization, inhibited the HGF-induced tubule formation without affecting neither
ccli scattering or growth. Therefore, these finding are evidence that nuclear signalling
is definitely required for HGF-induced branching tubulogenesis ofMDCK celis.
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1.5 Objectives
A model system consisting of invasive variants of Moloney sarcoma virus (MSV)
transformed MDCK cdils, that exhibits decreased expression of E-cadherin, was
selected for its capacity to pass through a Matrigel® coated liter unit (Behrens et al.,
1989; Sirnard et aï., 1 996). The resultant invasive MSV-MDCK ce!! variants (MSV
MDCK-INV) exhibit increased expression of t3-actin, the loss of actin stress fibers
and the expression of multiple -actin rich pseudopodia (Le et aï., 1998). The f3-actin
rich pseudopodia fotind in MSV-MDCK-INV cel!s express high leve!s of tyrosine
phosphorylation. Furthermore, among those proteins found to be selectively
phosphorylated on tyrosine in MSV-MDCK-INV cel!s, is a 1 6OkDa protein identified
as HGF-R or Met (Vadnais et aï., 2002).
In the present study, we examine the tumorigenic and transforrned characteristics of
MSV-MDCK-INV ceils in comparison to their MDCK and MSV-MDCK
counterparts. MSV-MDCK-INV cel!s express decreased levels of E-cadherin and
possess multiple 3-actin rich pseudopodia restilting in a motility that is flot observed
in either MSV-MDCK or MDCK cells. In addition, they express a high!y
phosphorylated c-Met which is invo!ved in various ce!lular transformations !eading to
turnorigenic abilities and has been observed in different cancers, name!y papillary
renal carcinomas. In order to assess the turnorigenic properties, we cultured MSV
MDCK-INV, MSV-MDCK and MDCK celis in soft agar, and observed the
respective focus-formation efficiencies and the size of resu!ting foci. Fol!owing the
growth in soft agar, foci were isolated from the semi-solid environment and placed
into culture in order to further examine other characteristics including their ability to
grow over a monolayer of well-poÏarized MDCK celis. These characteristics, as seen
previously, rank among the most important ones when c!assifying ceils as having
tumorigenic capacity.
Naving gathered evidence pertaining to the turnorigenic character of these MSV
MDCK-INV celis, the next step was to investigate the presence of point mutations in
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the tyrosine kinase as weII as the C-terminal domains of c-Met. Ail studies pertaining
to the analysis of Met’s role in cancer, for example in hereditary papillary renal
carcinorna, illustrate the presence of one or more point mutations in these domains
leading to their constitutive activation and phosphorylation. This constitutive
phosphorylation in turn leads to various cellular responses resulting in a transformed
phenotype arnong different cellular models. In order to elucidate the presence of point
mutations in both tyrosine and C-terminal domains of Met in MSV-MDCK-INV
celis, we performed RT-PCR reactions using RNA isolated from ah three ceIl unes
(MSV-MDCK-NV, MSV-MDCK and MDCK) in conjunction with primers
synthesized on the basis of the human c-Met DNA sequence. A subsequent
comparison of the DNA and protein sequences among the three celi unes helped
identify possible mutations that could account for the invasive and motile
characteristics of MSV-MDCK-INV ceils.
CHAPTER 2
Manuscript
A tumoral and invasive phenotype independent of c-Met mutation
Clinical Experimentat Metcistcisis, in revision process
G. Ciannini and J. Noél
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2.1 Abstract
Various studies have outlined the importance of c-Met in cellular transformation, ccli
motility and invasion. In the present study we aimed to determine if the transformed,
tumoral and invasive phenotypes observed in an invasive variant (INV) ofthe MDCK
ccli une transforrned by the Moloney Sarcoma Virus (MSV-MDCK) presenting,
under normal conditions, a highly phosphorylated c-Met were dictated by point
mutations in the tyrosine kinase and C-terminai domains of c-Met. RT-PCR from
total RNA extracts reveaied that there is no point mutations in the tyrosine kinase or
the C-terminal domains of MSV-MDCK-INV ceils’ c-Met when compared to
sequences of parental MSV-MDCK and MDCK celis. Therefore, the invasive and
tumoral character of MSV-MDCK-INV ceils, as determined by their capacity to form
foci in soft agar and colonies over a monolayer of well polarized epithelial celis, as
well as the transformed phenotype of MSV-MDCK cells may not be attribtited or
explained by the presence of point mutations in either of these two very important
domains.
Keywords
Anchoragc independent growth
Autocrine HGf loop
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Transformation
Tumor
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List of abreviations
Anchorage-independent growth (AIG)
Grb-2-associated binder 1 (Gabi)
Hepatocyte growth factor (HGF)
Hepatocyte growth factor receptor (HGf-R)
Invasive variant ofMoloney sarcoma virus transformed epithelial MDCK celis
(MSV-MDCK-INV)
Madin-Darby Canine Kidney (MDCK) celis
Moloney sarcoma virus (MSV)
Moloney sarcoma virus transformed epithelial MDCK celis (MSV-MDCK)
Phospholipase C gamma (PLC-y)
Phosphotyrosine (P-Tyr)
Protein encoding the protooncogene c-met (c-Met or Met)
Regulatory subunit ofPI3-kinase ofmolecular weight of 85 kDa (p85)
Reverse transcription-Polymerase chain reaction (RT-PCR)
Scatter factor (SF)
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2.2 Introduction
Cancer is a progressive disease that follows a course of increasingly
aggressive and treatment-resistant stages that involve the accumulation of molecular
and genetic changes. These changes are depicted through tumor initiation that
reflects unschedul.ed cellular hyper-proliferation, either through direct activation of
celi cycle machinery or of signaling pathways that regulate the ceil cycle [Ï].
Neoplastic transformation of hurnan cells and cells from other species in vitro
is seen as a complex multistep process by which normal celis acquire various
phenotypic characteristics. Four of these major steps are involved and are namely,
the development of morphological transformation, growth in semisolid medium,
immortality, and tumorigenicity. A large majority of human tumor ceils of
mesenchymal origin do portray the ability to grow in semi-solid medium otherwise
known as anchorage-independent growth or AIG t2].
The hepatocyte growth factor (HGF), also known as scatter factor (SF), is a
pleiotropic cytokine which, by activating its receptor tyrosine kinase, stimulates ceil
motiÏity, invasion, proliferation, survival and morphogenesis, and induces the
expression of specific genes such as ras, PLC-7, etc. [1]. Many groups have to date
established the importance of the hepatocyte growth factor receptor (HGf-R) or c
Met as well as the consequences of its over-expression and its constitutive
phosphorylation. Over-expression of the met proto-oncogene is evident in tumors of
specific histotypes including thyroid [3], pancreatic carcinomas [4], and in hercditary
papillary renat carcinomas (HPRC) [5]. Phosphorylatïon of two tyrosine residues in
the kinase dornain ofthe receptor (Y’231 and Y’235) positively regulates the enzymatic
activity of the c-Met kinase domain [6-8]. This increased activity can promote the
metastatic spread of cancer due to its stimulatory effects on a variety of processes
such as angiogenesis, cellular motility and protease secretion [9, 10].
Increased enzymatic activity in the tyrosine kinase dornain of c-Met is
translated into different cellular responses via the C-terminal domain. The C-terminal
domain contains a two-tyrosine docking site (Y’349 and Y1356) which, upon
phosphorylation, binds multiple SH2-containing transducers including the p85
subunit ofphosphatidylinositol 3-kinase [11], PLC-y [12, 13], Src [141, the adaptors
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Grb2 [15-17] and SHC [16, 18], the transcriptional factor Stat3 [12, 19], and the
docking protein Gabl (Grb-2-associated binder 1) [8, 9, 11, 20-22] (sec [23] for an
integrated view). A study from Guai et al. [24] lias recently dernonstrated that the
iast 26 amino acid portion of the C-terminal domain positively regulates c-Met kinase
activity and that its presence is critical for the transforming ability but not for c-Met
rnediated invasiveness. Furthermore, the introduction of the M10T point mutation,
which is known to up-regulate the kinase activity and interfere with the receptor’s
auto-inhibition mechanisms [10, 25], in the Met kinase domain can substitute for the
role of this portion of the C-terminal dornain [24].
The identification of germ-iine and somatic mutations, like the M1250T
mutation, in the met gene in papillary renal carcinomas [5, 26, 27] and childhood
hepatocellular carcinomas [28] lias established the connection between c-Met and
human cancers. An even more direct relationship lias been established between
mutations and metastasis [10]. Ail of the mutations found to date are focated within
the tyrosine kinase domain, either in the N-terminal portion, which contains the ATP
binding site, or in the C-terminai portion, which inciudes both the catalytic and
activation loops. Studies demonstrate that ail mutations reported so far activate the
catalytic activity of the receptor to different extents [10, 25] with some inducing
malignant transformation of NIH 3T3 cells [25].
Moloney sarcorna virus (MSV) transformants of the polarized epithelial MDCX
(Madin Darby Canine Kidney) ccli line were shown to exhibit a heterogenous
phenotype [29]. Characterization of two sub-populations showed celis with a
fibroblastoid phenotype possessing motile properties and a lack of E cadherin
expression, or ceils which were poiarized, less motile and expressing E cadherin [29].
Selection of celis for their abiiity to pass through a Matrigei®coated fiiter unit lcd to
a pure population of ceils of fibroblastoid phenotype called MSV-MDCK-INV for
their invasive property [31]. This invasive MSV-MDCK ccli variant exhibits multiple
13-actin-rich pseudopodia, the loss of actin stress fibers, and a highly phosphorylated
c-Met on tyrosines in position 1230, 1234, 1235 of the tyrosine kinase domain and in
position 1349 and 1365 of the docking site [32]. Having demonstrated that an
autocrine HGF loop could explain the motile phenotype of MSV-MDCK-INV celis
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as well as the pseudopod formation [32], we examined the possibility of point
mutations in both the tyrosine kinase and C-terminal dornains of c-Met among MSV
MDCK-INV celis. We demonstrate that flot a single point mutation in these domains
could account for the high responsiveness of c-Met in M$V-MDCK-INV celis to
secreted HGF. We also Ïooked at the ability of the MSV-MDCK-INV celis as
compared to their parental celi lines to grow in anchorage-independent environments,
namely in soft agar and on a well-polarized monolayer of epithelial MDCK ceils. As
expected from their invasive property, we found that MSV-MDCK-INV ceils are
similar in terms oftumorigenicity to ras-transformed NIH 3T3 celis.
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2.3 Material and methods
Cet! Culture
MSV-MDCK and MSV-MDCK-INV cells, as well as ail respective clones (MDCK
(clone E16), MSV-MDCK (clone TE6) and MSV-MDCK-INV (clone 5.1) were
obtained from Dr. Ivan Robert Nabi of the Pathology and Cellular Biology
Department of the University of Montreal (Montreal, Quebec). MDCK Strain I cells
were obtained from Dr. Guy Lemay of the Microbiology and Immunology
Department of the University of Montreal (Montreal, Quebec). NIH 3T3 as well as
NIH 3T3/ras ceils were obtained from the laboratory of Dr. Victor Sandor at the Lady
Davis Institute of the Jewish Generaf Hospital (Montreal, Quebec). MDCK Strain I,
MSV-MDCK and MSV-MDCK-INV celis, as well as the respective clones, were ail
cultured in High Glucose DMEM culture medium supplemented with 10% FBS, 1%
non-essential amino acids and 1% vitamins (supplied by Gibco BRL Life
Technologies, USA) under 5% C02 atmosphere. NIH 3T3 as well as NIH 3T3/ras
celis were cultured in High Glucose DMEM culture medium supplemented with 10%
FBS and 1% glutamine.
Soft Agar Assay
A basal agar layer was prepared one day prior to the assay in wells of a 6-well
culture plate and consisted of 0.5% noble agar, iX DMEM, 10% FBS, 1% non
essential amino acids and 1% vitamins. On the day of the assay, different cellular
dilutions were prepared in duplicates in order to yield 5000 cells/well, 10,000
cells/well and 20,000 cefls/well in culture medium containing DMEM, 10% FBS and
0.33% noble agar. Celis were then placed at 37°C under C02 atmosphere for a period
of 10-14 days with the addition of fresh medium every two days before being
observed. The growth efficiency was calculated from the number of resulting foci
counted throughout the agar in relation to the number of cells plated for the 6
conditions, and expressed as percentage.
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Phenotype ait atysis
MDCK ceil monolayers were prepared by plating 500,000 cells/well in a 6-
well culture plates containing coverslips. Once the monolayers were well polarized,
1000 cells were seeded over the monolayer and placed at 37°C under C02
atrnosphere for a period of 7-10 days, or until superficial colonies became visible.
This was perforrned in duplicates for MDCK, MSV-MDCK and MSV-MDCK-INV
celis as well as for sorne MSV-MDCK-INV and NIH 3T3/ras clones isolated from
soft agar. Following the observation of visible colonies on the monolayers, ceils
were fixed with a pre-heated solution (37°C) of 4% paraformaldehyde for 15 minutes
then washed with PBS-CM (Phosphatc-buffered saline containing 0.1 mM CaC12 and
lrnM MgCI2). Ceils were peniieabilized with a PBS solution containing 0.075%
saponin and 0.2% BSA for 10 minutes at room temperature, incubated in blocking
solution (PBS containing 2% BSA and 0.2% gelatin) at room temperature for 20
minutes, then, with Phalloidine Texas-Red. The coverslips were mounted with a
solution of 2% propyÏ-gallate in glycerol:Tris-HC1 200mM, pH 8.0 (1:1). CelIs were
visualized with a Zeiss AxioSkop fluorescence microscope equipped with a 63X Plan
apochromat objective and selective filter for Texas red.
Isolation ofRIVA.
Total RNA from MDCX, MSV-MDCK and MSV-MDCK-INV ceils cultured
in supplemented DMEM medium , was prepared by using the GenElute Total
Mammalian RNA Extraction KitTM (Sigma Biotech, Ontario).
R T-PcR.
f irst strand cDNA was reverse transcribed from 2.5 tg of total RNA
(Superscritpt 11TM Invitrogen, Gaithersburgh, Md.) with an antisense primer (h-TKA;
5 ‘-CACATTTTACATTCACATAAGTAGCGTTCA-3’) specific to the human tyrosine kinase
dornain of c-met ([33], EMBL access code: #J02958) chosen 20 nucleotides away
from the 3’(antisense) end. The canine c-met cDNA was arnplified using Tciq DNA
Polymerase®, a sense primer specific to the human tyrosine kinase domain of c-met
chosen 20 nucleotides away from the 5’ (sense) end (h-TKS; 5’-
GGATAGGCTTGTAAGTGCCCGAAGTGTAAG-3’) and the h-TKA primer.
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To analyze the C-terminal domain of c-Met, an antisense primer, h-CTA, specific to
the 3’-end of the human C-terminal dornain and containing a poly-dT tau (5’-
CTATGATGTCTCCCAGAAGGTTTTTTITTT-3’) was used for the initial reverse
transcription reaction. The following PCR reaction involved the use of this h-CTA
primer and a sense primer, c-TKIS, which was synthesized based on the internai
canine tyrosine kinase domain sequence (5’- AAACATGGAGATCTTCGAAATTTCA-3’).
The respective PCR reactions were performed using an MJ Research PTC-2000
Peltier Thermal Cycler, with 30 cycles at an annealing temperature of 65°C and an
extension temperature of 72°C. Amplified DNA was analyzed through gel
electrophoresis and purified using the GenElute PCR Clean-up kit (Sigma
Biotechnology) before proceeding to the DNA sequencing.
DNA Sequencing.
Two sequencing reactions using purified DNA fragments and both sense and
antisense primers were perfonned per DNA sample in order to ensure the complete
sequencing of the entire tyrosine kinase domain as well as the entire C-terminal
domain of the canine c-Met. Ail sequencing reactions were performed by The
Sheldon Biotechnology Centre ofMcGill University, (Montréal, Québec, Canada).
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2.4 Results and Discussion
Constitutive activation of the met proto-oncogene bas for some time been
elucidated as being involved witb cellular transformation and responsible for invasive
and metastatic properties in cancer ceils [23, 34]. The constitutive auto
phosphorylation of c-Met, its over-expression and the presence of point mutations are
ail elernents responsible for the conversion of physioÏogically active c-Met to
oncogenic forms [3, 26, 27, 35-39].
Tise invasive variant of MSV transformed MDCK cetis presents characteristics of
tumoral ceits.
Tumoral celis depict characteristics, which encompass a changed morphology
and a capacity to grow under conditions where normal celis cannot. One such
condition is anchorage-independent growth (AIG). Transformation of certain ceil
unes with viruses bas been shown to induce AIG and the acquisition of this AIG in
rnany immortal rodent ceil unes has been sbown to coirelate wel] with tumorigenic
growth [40]. To date, the invasive character of MSV-MDCK-INV ceils was shown to
be related to activation of an autocrine HGf loop [32] but the tumoral phenotype has
of yet not been elucidated. When placed in an anchorage-independent environment,
namely soft agar, MSV-MDCK-TNV celis formed foci of comparable size to what
was observed for NIH 3T3 celis transformed by the ras oncogene (a highly
tumorigenic celi line) (Figure 2.1 a). In addition to size similarities, MSV-MDCK
INV ceils grew at an efficiency quite comparable to what was observed for NIH
3T3/ras celis (Figure 2.1 b-c). Colony formation in soft agar was also observed for
MDCK as well as MSV-MDCK cells, but the size as welÏ as the growth efftciency in
relation to MSV-MDCK-INV ceils was incomparable. This is quite interesting
especiaily when considering that MDCK celis grow faster than MSV-MDCK and
MSV-MDCK-INV cells under normal culture conditions and in the presence of 10 %
FBS (data not shown). Moreover, when ceils isolated from the soft agar foci were
seeded over a monolayer of wefl polarized epithelial MDCK celis, only MSV
MDCK-INV ceÏÏs (Figure 2.2 A,B) and NIH 3T3/ras ceils (Figure 2.2 E,f) but not
MDCK and MSV-MDCK celis, had the capacity to grow and form superficiaÏ
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colonies. The original MSV-MDCK-INV (Figure 2.2 C,D) and NIH 3T3/ras celi
populations (not shown) also possess the capacity to grow on a monolayer of
epithelial celis, whereas MDCK and MSV-MDCK celis do flot. This particular
characteristic arnong MSV-MDCK-INV ceils illustrates another property that serves
as further evidence in the classification of these ceils as tumoral and metastatic.
Indeed, the first step involved in extravasation of a tumor ceil through a capillary,
when referring to the development of a metastasis, is the adhering of the celi to the
basement membrane. It is only after the celis have adhered that they eau proceed with
the enzymatic digestion and movement through the basement membrane [34].
Tite invasive phenotype and the high tevet of c-Met tyrosine phosphoiytation
cannot be exptaùted by point mutations lit tue tyrosine kinase and C—terminal
domains.
Guai et al. [24] associated the importance of the last 26 amino acids within
the C-terminal domain of c-Met on the actual enzymatic activity of the tyrosine
kinase domain which is critical for ceii transformation but dispensable for invasive
properties. furthermore, they eiucidated the importance of the last 47 amino acids in
the triggering of various signalling pathways leading to cellular responses such as ceil
motility. This C-terminal domain contains the multi-functional docking site
comprising two tyrosine residues, Y’349 and Y’356, which when phosphorylated binds
to and activates accessory proteins involved in the signal transduction of various
cellular responses (see [23] for an integrated review). Based on this study, we
assumed a possible role for this region within the C-terminal domain of c-Met and
hypothesized the presence of mutations which could explain the invasive and tumoral
properties of the transformed MSV-MDCK-INV ccii une. To determine if mutations
were in fact present, we perforrned a RT-PCR reaction on the C-terminal domain of
c-Met using total RNA extracts from ail three cell unes and then proceeded to
automated DNA sequencing. Foliowing the sequence analysis for the three respective
celi unes, we were abie to conclude the absence of point mutations in the C-terminal
domain of c-Met for ail three ccli unes. A sequence analysis and comparison among
species, as depicted in Figure 2.3, demonstrates that the C-terminal dornain is
somewhat homoiogous at the 5’ end but loses its hornology as one approaches the 3’
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çnd. This is a phenornenon that seems to be fairly common arnong different species.
Human c-Met antibodies that do recognize the canine c-Met were synthesized on the
basis of the N-terminal portion of the protein as opposed to the C-terminal domain.
However, existing human antibodies synthesized on the basis of the C-terminal
domain do flot function as weB in terms oftheir canine sequence recognition.
In order to continue defining the mechanism behind the constitutive
phosphorylation of c-Met among the MSV-MDCK-INV ccli une [32], which is
seemingly one of the main reasons why this transforrned, invasive and tumoral
phenotype is observed, we assessed the possibiiity of point mutations in the tyrosine
kinase domain. To do so, we performed a RT-PCR reaction using the same conditions
used for the C-terminal domain but with different primers, and then proceeded to
automated DNA sequencing. The comparison of the three canine amino acids
sequences (MDCK, MSV-MDCK and MSV-MDCK-INV) reveais no point mutations
in the tyrosine kinase dornain of c-Met. These resuits indicate that the transformed
phenotype ofMSV-MDCK celis as well as the tumoral and invasive phenotype ofthe
MSV-MDCK-INV ccli une cannot be explained by c-Met’rnutations. Analysis of 25
cancer ccli unes by others lcd to the same conclusion [10]. However, as Lorenzato et
al. [10] found in a iung metastasis of a testicular gcrrn ccli tumor, we noticed the
presence of suent bases changes between total populations of the three ccli unes
(Figure 2.4). Given their nature of affecting only the nucleotide sequence of the gene
and not the amino acid composition of the protein, we can only acknowledge their
presence but not assume any particular role on their part with regards to the
transfornied phenotype observed arnong MSV-MDCK ceils, nor the invasive
phenotype observed among MSV-MDCK-INV ceils.
In order to further analyze the obtained canine c-Met sequence and to assess
the importance of these suent mutations, we performed the saine set of experiments
on clones derived from the three cdl lines; MDCK (clone E16), MSV-MDCK (clone
TE6) and MSV-MDCK-INV (clone 5.1). Interestingly enough, these ccli unes’
sequences, whether considered at the DNA levei or the protein level, expressed no
point mutations or suent base changes. Thus, this resuit enabled us to consider the
possibility of a heterogeneous population among our previous total population ccli
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unes. It should be recalled that this total population is in fact composed of various
invasive ceils selected on the basis oftheir ability to pass trough the Matrigel® filter.
Our resuits nonetheless establish a partial (kinase domain and C-tenriinal domain)
canine c-Met DNA sequence that can prove to be important for many reasons. Iwo
main reasons being; the cloning of the canine c-Met and the production of specific
canine c-Met antibodies, which up to date remain unavailable.
Many cancers, as seen previously, do possess point mutations in the kinase
domain of c-Met leading to its auto-phosphorylation t26-28, 35, 42]. On the other
hand, certain human cancers, for example the human gastric carcinoma celi une GTL
16, possess an over-expressed c-Met without expressÏng any point mutations in the
kinase domain [43]. Our findings that MSV-MDCK-INV celis expressed comparable
arnounts of c-Met proteins to the parental ceil unes but highly phosphorylated [32]
were thus suggestive of the presence of point mutations or the presence of an active
autocrine HGF loop. The present study clearly dernonstrated the absence of any
change in the amino acid composition of the tyrosine kinase and C-terminal domains
of c-Met in either M$V-MDCK or MSV-MDCK-INV cells. Point mutations in
neither the C-terminal nor the tyrosine kinase domains may explain the transformed
phenotype observed among MSV-MDCK ceNs and the invasive/tumoral phenotype
observed among MSV-MDCK-INV ceils. Recent studies by our group [32] as well as
others have brought to light the presence of an autocrine loop, which allows the
constitutive activation of c-Met through auto-phosphorylation of its kinase domain.
MSV-MDCK-INV celis secrete their own HGF/SF in close proximity to the HGF-R,
allowing an immediate and continuous activation of c-Met through an
autophosphorylation. In turn, this activation leads to a cascade of signais leading to
the triggering of various ceil responses such as ceil rnotility and invasiveness. The
same was observed in murine rnammary carcinoma (SP1) ceils [44] where in vitro
translation of mRNA and metabolic labelling confirmed expression and synthesis of
HGF by SPi cells. Moreover, in a study performed by ferracini et al. [36] with
human specimens of osteosarcoma, il was shown that the c-Met/HGF receptor was
constitutively phosphorylated and treatrnent with surarnin, a known blocker of
autocrine loops which non-selectively interferes with the binding of growth factors to
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their receptors and inhibits the secretion of growth factors [45], suppressed that
phosphorylation. Therefore, it xvas suggested that c-Met/HGF receptor activation via
a paracrine or autocrine route might play a very important foie in the aggressive
behaviour observed among these hurnan osteosarcomas.
From this study, we demonstrated the tumoral phenotype of MSV-MDCK-INV ceils
through their capacity to grow in anchorage-independent environments. Based on the
absence of point mutations in either the C-terminai or the tyrosine kinase domains of
c-Met, we conclude that the major mechanism leading to the activation of the kinase
domain of c-Met, to invasion and to the tumoral phenotype observed among M$V
MDCK-INV celis, wouid be the autocrine HGF activation loop [32]. The transformed
phenotype of MSV-MDCK ceils, being not explained by the autocrine HGF loop or
the presence of mutations in c-Met, would involve another undefined mechanism.
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Figure Jegends
figure 2.1
Growth effieiençv in soft agai a) Panels A to D represent typical colonies formed
from each of the three canine celis unes (A: MDCK, B: MSV-MDCK, C: MSV
MDCK-INV) and the control NIH 3T3/ras ceil une (D) grown in soft agar. Figure lb
depicts the cellular density of colonies from each of the four celi unes (A-D as
above). Each ofthe respective ce!! unes were plated at a density of 10,000 cells/wel!
and pictures were taken approximately 14 days following the plating date. Figure I c
illustrates the growth efficiencies of al! four ceil unes from two independent trials.
The mean growth efficiency was obtained by dividing the number of colonies
counted by the original number of cells plated, expressed as percentage, and taking an
average of each independent replicate. Bar 100 t (a) and 2 mm (b), applicable for
figures A,B,C and D.
figure 2.2
Abitity of MSV-MDGK-INV tike NIH 3T3/ras cetis to grow on a monotayer of
epithetiat ceits. Illustrations A-D and E-f represent MSV-MDCK-INV ce!!s and
NIH 3T3/ras cells respectively, grown on a po!arized monolayer ofepithelia! MDCK
cells, strain I. Illustrations A, C and E were taken while focusing on the MDCK
monolayer whereas illustrations B, D and f were taken in the sarne visual plane but
focussing on the colony. Cells were labelled for F-actin with phalloïdine-TR.
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figure 2.3
Sequence comparison betweeit the canine c-Met c-terminal domain and ‘that of
other species. To analyze the C-terminal domain of c-Met, an antisense primer
specific to the 3’-end of the human C-terminal domain and containing a poly-dT taiÏ
(5’-CTATGATGTCTCCCAGAAGGTTTTTTTTTT-3’) was used for the initial reverse
transcription reaction with total RNA of wild type MDCK. Two sequencing reactions
using purified DNA fragments and both sense and antisense prirners were performed
per DNA sample obtained from two independent RT-PCR. Sequence comparison of
the canine c-Met with that of others species was performed with data obtained from
Gene Bank
figure 2.4
Suent mtttations observed in the tyrosine kinase of c-Met in MSV-MDGK-INV
cells. DNA sequences obtained for the tyrosine kinase domain of the three cdl unes,
MDCK (M), MSV-MDCK (MSV) and MSV-MDCK-INV (INV), were aligned to
look for the presence of DNA mutations. DNA sequence were then translated to
amino acid sequence. Although DNA mutations were reproducibly found in both
MSV-MDCK and MSV-MDCK-INV as compared to the parental MDCK ccli une,
these DNA mutations do no translate in changes in arnino acids. Only suent
mtitations were found.
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Figure 2.3
Homology ta
canine sequence
Canine S’—A I---Y’349-HV---Y”—V—V SSQD-IDGEGDT-3’
H.Sapiens 5 —A I---Y’349-HV---Y”—V—V SSED-ADDEVDTRPASFWETS-3’ 96%
M.Musculus S’—S I---Y”-HV---Y’356—V—V PSQD-IDGEGNT-3’ 95%
R.Norveg. S’—S I---Y’3”-HV---Y”—V—V PSQD-IDGEANT-3’
G.Gallus S’—T I---Y”49-HV---Y”5’—V—V SSQD-TDMDVDT-3’
X.Laevis S’—S L---Y”-LF---Y’356—I—A SPEG-IEFSIDT-3’ 90%
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Figure 2.4
3550 3698 3788 3967 4011 4014 4087 4098
M 5’ AAA GGG---TCT GGC--GGG-GTC---CTC—GGA--3’
NH2 (Lys)--- (Gly)
-- (Ser) (Gly) (Gly) (Val) (Leu) (Gly) -CO
MSV 5’ AAA GGA---TCC GGG--GGC-GTG---CTC-GGA--3’
NH2 (Lys)---(Gly)--(Ser) (Gly) (Gly) (Val) (Leu) (Gly)-CO
INV 5’ AAG GGA---TCC GGT--GGG-GTG---CTG-GGG--3’
NH2 (Lys)---(Gly)--(Ser) (Gly) (Gly) (Val) (Leu) (Gly)-CO
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CHAPTE R 3
DISCUSSION
65
3.1 Study overview
Constitutive activation of the met proto-oncogene lias for somctime been elucidated
as being involved with cellular transformation and responsible for invasiVe and
metastatic properties in cancer ceils (ftirge et al., 2000; Comoglio et cii., 1999). The
constitutive auto-phosphorylation of c-Met, its over-expression and the presence of
point mutations are ail elements reported to be responsible for the conversion of
physiologically active c-Met to oncogenic forms (DiRenzo et al., 1992; Schmidt et
aï., 1997; Schmidt et al., 1999; Sclmiidt et al., 199$; Ferracini et al., 1995; Cooper et
al., 1984; Park et aï., 1986; Rong et al., 1994). In this study, we examined the
tumoral characteristics of celis expressing a highly phosphorylated c-Met (M$V
MDCK-TNV) and the possible implications of c-Met, either through the presence of
activating mutations or via other rnechanisrns. Like other research groups working
with c-Met, we aimed to analyze the possible presence of point mutations in two very
influential domains, namely the tyrosine kinase and C-terminal domains, which
would help explain the highly phosphorylated and hence highly active c-Met in these
MSV-MDCK-INV ceils. In observing the cells’ invasive phenotype and their ability
to invade a Matrigel®-covered filter, we were imrnediately drawn to identifying
specific mutations in c-Met that would help explain why these phenotypic
characteristics exist only among these invasive ceils and not their predecessors.
Furthermore, explaining the transformed phenotype observed among the Moloney
sarcorna vints-transformed MDCK ccli une was also of interest to us. Indeed, while
rnany mutations in c-Met were reported to be present in different cancers (Schmidt et
ai., 1997; Schmidt et al., 1999; Schmidt et al., 199$; Park WS et aï., 1999; Jeffers et
al., 1997; Maritano et al., 2000), there are oniy some mutations reported as being
present in metastases ofpapillary renal carcinomas (Schrnidt et al., 1997; Schmidt et
al., 1999) and childhood hepatocellular carcinomas (Park WS et aÏ., 1999). These
mutations were shown to induce metastasis when cells expressing the cDNA
constructs were injected in mice (Jeffers et aÏ., 1997).
The main goal of otir study is to contribute to the identification of mutations within
the c-Met oncogene that, in long terni perspective, would help in the possible
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development of diagnostic kits which could be used in the identification of a mutated
c-Met in patients before a possible cancer begins metastasizing. The most daunting
prognosis for a cancer patient is to be toid that the metastasis process lias started.
Treatment at this stage of the disease is quite difficult especially when considering
that cancer ceils travel and invade other tissues and/or organs.
Our working strategy for this study consisted of first identifying mutations in the
canine c-Met of MSV-MDCK-INV celis and then transfecting MDCK celis and
NIH3T3 cells with human c-Met containing the respective mutations. This would
help assess the possibility of producing the invasive phenotype and functional
changes observed among MSV-MDCK-INV celis in MDCK ceils. In accordance to
the resuits obtained from the first part of the project and depending on time
constraints, the next step we set out to examine was the tumoral and metastatic ability
ofthe transformed MDCK and NIH3T3 celis by injecting into nude mice.
Our efforts to sequence both the tyrosine kinase and C-terminal domains among the
three ce!! lines as well as specific clones derived from the respective celi unes proved
to be a success. By using primers synthesized on the basis of the human c-Met, we
were able to ampÏify the same gene in canine celis. Unfortunately though, no
mutations were found within the c-Met of MSV-MDCK-INV ceils as cornpared to
MSV-MDCK and MDCK ceils. for this reason, we were unable to pursue this
avenue of our research project. We did nonetheless report our findings in an article
submitted to Clinical Experimental Metastasis (in revision) that acknowledged our
hypothesis and efforts. In addition, we took the opportunity to characterize the
tumoral properties ofthe MSV-MDCK-INV ceil line in comparison to both the MSV
MDCK and MDCK ccli unes. First, we piaced ail three ceil unes in soft agar medium
and analyzed their growth pattems. Next, we cultured ceils from isoiated soft agar
colonies and exarnined their ability to form superficiai colonies over a monolayer of
epithelial ceils.
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3.2 Growth properties ofMSV-MDCK-INV ceils in soft agar ami on a
monolayer of epithdllal ceils.
Transformation of certain celi unes with viruses lias been shown to induce AIG and
the acquisition of AIG has been shown to correlate welI witli tumorigenic growth in
many immortal rodent ceil unes (Sliin et al., 1975). The invase cliaracter ofthe MSV
MDCK-INV ce!! model lias been established previously (Le et al., 1998; Vadnais et
al., 2002), but the tumoral plienotype lias yet to be elucidated. Hence, one oftlie first
objectives in this study was to assess tlie growtli of these invasive celis in an
anchorage-independent environment, soft agar, and compare it to the growtli pattems
obseiwed for the parent celi unes MSV-MDCK and MDCX. We reported that foci
formed from M$V-MDCK-INV and NIH3T3/ras cells (cells that were transformed
by the ras oncogene and express highly tumorigenic cliaracteristics) were sirnilar in
size (Figure 2.1 a-b). MSV-MDCK-INV cells also displayed growth efficiencies
quite comparable to NIH3T3/ras celis (Figure 2.lc). Altliough M$V-MDCK and
MDCK celis did grow in soft agar, their growth efficiency and tlie size of their
respective foci were rnuch lower than observed for tlieir invasive variant despite their
overall comparable growtli rates. In fact, these MSV-MDCK-INV cells do not grow
faster than either MDCK or MSV-MDCK celis in culture. Therefore, their capacity to
form large foci in soft agar at a fast rate may result from tlieir ability to grow in an
independent way, possibly tlirougli secretion ofHGF.
The celis from each respective celi une grown on soft agar were subsequently
isolated and kept in culture. In addition to growing in soft agar, tumoral ceils should
grow and strive over a monolayer ofepitlieliaÏ ceils. Tlie ability ofMSV-MDCK-INV
ceils to replicate once seeded over a monolayer of MDCK epitlielial ceils was thus
tested. Resuits illtistrated in Figure 2.2 sliowed tliat soft agar MSV-MDCK-INV
ceils, like tlie soft agar NIH3T3/ras cells, could replicate and form superficial
colonies unlike the soft agar MSV-MDCK and MDCK cell lines. furtliermore, the
original MSV-MDCK-INV and NIH3T3/ras ce!! populations (not sliown) formed
superficial colonies over the monolayer, whereas the MDCK and MSV-MDCK
parent ceil unes did flot. In theory, the first step involved in extravasation of a tumor
cdl tlirougli a capillary, wlien referring to the development of a metastasis, is the
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idhering of the ceil to the basement membrane. It is only after the celis have adhered
that they can proceed with the enzymatic digestion and movement tlwough the
basement membrane (Chambers and Hill, 1998). In this assay, epithehal MDCK celis
form the tight monolayer onto which MSV-MDCK-INV ceils adhere and grow. It is
almost comparable to a tumor attaching to and penetrating through tissue. It wouÏd be
of great interest to examine, would such an assay exist, whether or not these
superficial colonies have managed to penetrate through the monolayer, or if celis
forming the respective colonies just strive off of the celis forming the monolayer
without penetrating. From the data shown in Figure 2.2, it is proposed that ceils are
able to penetrate through the monolayer and grow to form larger colonies.
The observation that MSV-MDCK-INV celis form foci in an anchorage-independent
environment is a very good indication of their tumoral capacity. This observation
though, does not specify any particular role of c-Met or HGF in the tumoral process.
We already know that c-Met is involved with the invasive and motile phenotype of
MSV-MDCK-INV cells (Vadnais et al. 2000), but the role of activated c-Met in
anchorage-independent growth has yet to be established. The best way to investigate
this phenomenon would be to seed the celis in a normal culture medium containing
the normal levels of growth factors, but to remove any trace of HGF through titration
with a u-HGF antibody sirnilar to what was performed by Vadnais and collaborators
(Vadnais et al., 2002). These resuits would definitely enable one to firrnly establish c
Met and HGF’s role in AIG arnong MSV-MDCK-INV celis. We however, did not
proceed in performing these critical experiments. These experiments could become
quite costly since anti-HGF would need to be added at high concentrations (5-20
ag/ml) and the culture medium (2m1) changed every two days for a period of 14 to 1 8
days. This procedure would have to be perforrned in triplicates in order to obtain one
resuit.
Subsequently, cells grown on the epithelial cdl monolayers should be studied in
order to assess the role of HGF andlor c-Met in this phenotype. One feasible
approach would be trypsinizing the cells and analyzing the level of c-Met
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phosphorylation among the detached celis. If in fact c-Met is involved in their
growth, then one may expect c-Met to display a higher level of tyrosine
phosphorylation in MSV-MDCK-INV celis. Once again, as described in the
preceeding paragraph, a Œ-HGF antibody should be used to remove any trace of HGF
in the culture medium to establish whether HGF and/or c-Met activation were
involved. This approach would also ensure that if the ceÏls do produce HGF via an
autocrine process (Vadnais et aÏ., 2002), and if this HGF secretion is essential for
their growth on a monolayer, they would stop forming colonies and resemble their
MDCK and MSV-MDCK parent cclls.
As mentioned earlier, some of the assays described above can be quite costly. One
other possibility would be to take advantage of the fact that these invasive celis
secrete their own HGf via an autocrine activation ioop (Vadnais et al., 2002) and
apply an inhibitor, such as surarnin, that would interfere with both the secretion of
HGF and binding ofHGF to its receptor blocking the autocrine activity (Benini et aï.,
1999). If the inhibitor succeeds at blocking the binding of HGF to its receptor and the
subsequent activation of c-Met while sirnultaneously eliminating the capacity of these
celis to form foci in soft agar and colonies on epithelial monolayers, then one may
suspect involvement of c-Met activation.
A point worth remembering is that ceils require certain growth factors and cellular
interactions with the extracellular matrix for successful proliferation. For this reason,
it would be of great interest to carry ont the seeding of MSV-MDCK-INV celis over
monolayers of cancer celis derived from different organs (e.g. colon cancer celis,
liver cancer celis, etc...). If these invasive ceils do in fact have the capacity to form
colonies over the respective monolayers, analysis of the conditioned culture media
would yield valuable information with regards to what growth factors or particular
conditions are required for their growth. Therefore, it would help in understanding
what allows these cells to proliferate under conditions where normal cells cannot.
70
One of the most important aspects that should be considered in future
experimentation is the further classification of the MSV-MDCK-INV cd une as a
turnorigenic ceil une. Many ofthe preliminary steps like the growth in soft agar and
the growth over a monolayer of epithelial celis have been analyzed already, but
another important aspect worth examining would be the celis’ capacity to form
tumors in vivo. The initial stages of the in vivo study should involve the injection of
MSV-MDCK-INV, MSV-MDCK, and MDCK ceils into nude (athymic) mice to
examine the incidence as well as frequency of tumor formation. A dissection of the
resulting tumor and the culturing of tumoral celis for future analysis would also be of
great value in understanding c-Met’s role in tumor formation. If one would like to
take this a step further, then another possibility would be looking at the culture
medium in which these tumor ceils grow, and determining its composition with
regards to growth factors. The addition of autocrine activation loop inhibitors would
also prove to be very useful especially in deducing whether or not the growth of cells
that have rnetastasized can be blocked.
3.3 Absence of point mutation in the tyrosine kinase and C-terminal domains of
c-Met
The tyrosine kinase domain of c-Met has for a long time been eÏucidated as being die
enzymatic powerhouse of c-Met. In order to define the mechanism behind the
constitutive phosphorylation of c-Met among the MSV-MDCK-INV celi Hue, which
is seemingly one of the main reasons why this transformed, invasive and tumoral
phenotype is observed, we assessed the possibility of point mutations in the tyrosine
kinase domain, especially ones affecting the two tyrosine residues essential to the
induction of enzymatic activity. We perfonned a RT-?CR reaction on the tyrosine
kinase dornain of c-Met using total RNA extracts from all three cdl unes and then
proceeded to automated DNA sequencing. A comparison between the prirnary
nucleotide sequences obtained from the parental strain I MDCK cell une and those of
other species reveals 96 % homology between the canine and the human sequence,
95% hornology between the canine and the rat sequence, and 95 % between the
canine and mouse sequences. It is clear from these numbers that evolution preserved
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this amino acid sequence due to the unequivocal role ofthe tyrosine kinase domain in
c-Met activity.
Sequence analysis of the tyrosine kinase domain of c-Met among MSV-MDCK and
MSV-MDCK-INV cells as well as the sequence analysis of the tyrosine kinase
domain of c-Met between MDCK and MSV-MDCK celis reveals no change in amino
acid sequence for the 1100 nuc]eotides sequenced. These resuits indicate that the
invasive phenotype observed ftom the MSV-MDCK-INV ccli une caimot be
attributed to a single point mutation within the tyrosine kinase domain of c-Met.
Other regions of the c-Met protein, other proteins, or other mechanisrns could
however explain these phenotypes.
In the last few years evidence bas been provided which demonstrates that the
enzymatic activity of the tyrosine kinase domain of c-Met is controlled via other
factors. Guai and collaborators pointed out the importance of the last 26 amino acids
within the C-terminal domain of c-Met with the enzymatic activity of the tyrosine
kinase domain which is critical for ccli transformation but dispensable for invasive
properties (Guai et al., 2001). Furtherrnore, they examined the importance of the last
47 amino acids and the role this region plays in triggering different factors involved
with various signaliing pathways leading to cellular responses such as celi motility.
As stated in Chapter 1, the C-terminal domain contains the multi-functional docking
site comprising two tyrosine residues, Y1349 and Y1356, which when phosphorylated
bind to and activate accessory proteins involved in the signal transduction of various
cellular responses. Based on these studies and considering that no mutations were
found within the tyrosine kinase domain of c-Met between MSV-MDCK-INV and
MSV-MDCK cells, and between MDCK and MSV-MDCK celis, we assumed a
possible role for a specific region within the C-terminal domain of c-Met and
hypothesized the presence of mutations which could explain the invasive and tumoral
properties of the transformed MSV-MDCK-INV cell une. To do so, we performed
RT-PCR using the same conditions like the ones used for the tyrosine kinase domain
but with different prirners. For this set of experirnents as well, we used the human c
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Met sequence as a template for the design of the primers. Sequence analyses among
the different species (data not shown) enabled us to observe that the 5’ end of the C
terminal dornain rernains quite hornologous. The 3’ end on the other hand i much
less homologous with regards to the various species. It is no wonder therefore. that
the rnajority of human c-Met antibodies that recognize the canine c-Met protein were
synthesized by using the N-terminal dornain of the protein as a template instead of the
C-terminal domain. In fact, ail existing human antibodies produced on the basis of the
C-terminal dornain do not function appropriately with regard to recognizing the
canine c-Met sequence (c-28 of Santa-Cruz and DQ-13 from Upstate Biotechnology).
It is worth mentioning however that the DO-24 antibody (Upstate Biotechnology),
which recognizes the N-terminal region of c-Met, yields reasonably good resuits
when performing an immunoprecipitation assay, but fails to produce any signal on
simple cellular lysates when performing a Western Blot (Vadnais et al., 2002; Prat et
m’., 1991). This emphasizes the importance, in some cases, ofthe native conformation
of the epitope in addition to the primary amino acid sequence of the protein for
antibody recognition. It was only by combining the biotinylation of surface proteins
to a c-Met immunoprecipitation in the presence of the DO-24 antibody and revealing
the biotinylated c-Met protein with streptavidin-HRP, that our laboratory was able to
quantify the surface expression of c-Met (Vadnais et aÏ., 2002).
Although the results obtained with regard to the sequencing of both the tyrosine
kinase and C-terminal domains of c-Met among the three cell lines failed to
demonstrate the presence of any point mutations which would help explain the
invasive and transformed phenotypes observed among MSV-MDCK-INV and MSV
MDCK cells respectively, they did nonetheless help establish a partial (kinase domain
and C-terminal domain) canine c-Met DNA sequence. There are quite a few
advantages in knowing the canine c-Met sequence, especially to produce specific c
Met antibodies which up to date remain unavailable. This would help eliminate the
dilemma presented previously where human antibodies recognize the N-terminal
domain of the canine c-Met and not the C-terminal domain. When working with an
antibody synthesized on the basis of the canine c-Met, the assay, whether it be an
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immunoprecipitation or a Western Blot on simple cellular lysates, should yield
similar resuits when working with canine celi lysates. Another important advantage is
the cloning of the canine c-Met DNA sequence. To date, just over three thousand
studies have been published with relation to MDCK celis and c-Met. Knowing the
canine c-Met sequence would definitely be useful to research groups who want to
study the effect ofnovel mutations in c-Met of canine ceils, and to those interested in
establishing a canine genornic sequence.
Having established the fact that no point mutations existed in c-Met between the
MDCK, MSV-MDCK and MSV-MDCK-INV ceil unes, our curiosity led us to
further examine the DNA sequence of the respective cell unes. To our surprise, we
discovered the presence of suent mutations between the total populations of the
different ccli unes. Suent mutations are referred to as “suent” because they do not
induce a change in the amino acid sequence of a protein, thus not resulting in a
mutation, but oniy result in changes of the nucleotide sequence. For this reason, we
can only identify their positioning with respect to the canine c-Met tyrosine kinase
domain. The importance of acknowledging the presence of silent mutations arises
when one considers the synthesis of an antibody against the tyrosine kinase domain
of the canine c-Met. In such a case, the areas on the sequence where rnost of these
suent mutations are located may be considered sensitive or susceptible to mutation,
especially after celis have been exposed to an environmentai stress or transforming
agents such as a virus.
Moreover, due to the fact that we were working with two strains of the original
MDCK ceil une (i.e. Strain I; from a tight epithelium and Strain II; from a loose
epithelium), and because Strain II illustrated a more scattered phenotype, we wanted
to assess the possibility of mutations between these two strains. Once again we
performed a RT-PCR experiment with prirners designed on the basis of the human e-
Met sequence. Sequence analysis of the two strains did not show evidence of point
mutations within either the tyrosine kinase dornain or the C-terminal domain of these
celis. Therefore, we believe that another mechanism exists which can explain the
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more scattered phenotype observed among Strain II cells. Further experimentation
would be required to examine the possible mechanism behind this difference in
phenotype, but unfortunately, this would require a substantial amount of time.
In order to ascertain the resuits obtained with regards to the DNA sequences and the
suent mutations identified, and in order to evaluate the importance of the suent
mutations, we continued our analysis by performing the same assays on single clones
derived from the MDCK cell une (clone E 16), the MSV-MDCK celi line (clone TE6)
and the MSV-MDCK-INV ceil une (clone 5.1). The results we obtained with this set
of experiments were very interesting and helped confirm certain aspects of our celi
unes. A comparison of the sequences obtained from ail three celi unes at the protein
level and at the DNA level did not reveal any point mutations or suent mutations in
the tyrosine kinase and C-terminal domains of c-Met. This is in comparison to the
parental MDCK Strain I cell une. Therefore, this resuit was extremely valuable
because it raised the possibility that the two transformed total population cell lines
studied initially may be heterogeneous populations. In other words, if we take for
example the total population MSV-MDCK-lNV ceii une, we can assume that it
contains various clones ail of which are invasive, but at different degrees.
RT-PCR amplification of the canine tyrosine kinase and C-terminal dornains of c-Met
from total RNA proved useful in determining the presence or absence of mutations
among the three respective celi lines. As mentioned earlier in this report, the canine
DNA sequence for c-Met has yet to be published. Therefore, we were obliged to use
the human DNA sequence as a template for the design of primers. Another approach
that one might consider taking is the actual cloning of the entire canine c-Met protein
including the tyrosine kinase and C-terminai domains. Indeed, we cannot mie out the
possibility that a point mutation or an amino acid deletion elsewhere within the
protein could influence the autophosphorylation or subsequent activity of the
receptor. Cloning the canine cDNA wouid of course take a substantial amount of
time, but would be extremely useful for everyone working with canine cells. As seen
previously, it could help in the synthesis of antibodies specific to the canine sequence
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or even in assessing the effects of nove! point mutations on cellular responses
including motility and invasiveness. In addition, it would be a plausible start to the
mapping of the canine genome.
The resuits demonstrating the absence of point mutations in both the tyrosine kinase
and C-terminal domains of the canine c-Met are very important in helping us solve
the molecular mechanism behind the invasive phenotype expressed by MSV-MDCK
INV celis. Indeed, two hypotheses were proposed initially and they involved the
presence of point mutations in the tyrosine kinase and C-terminal domains of c-Met,
an activating HGF ioop, or both taken together. In the present study, we demonstrated
that mutations in c-Met cannot explain the high level of c-Met autophosphorylation
and hence the invasive phenotype. Therefore, this leaves us only with the autocrine
HGF activation ioop which has been examined extensively by Vadnais and
collaborators as the possible mechanism behind c-Met’s increased activity and the
invasive character of MSV-MDCK-LNV ceils (Vadnais et cii., 2002).
The autocrine HGF activation ioop, as its name implies, involves the secretion of
HGF from the ceil in close proximity to the celi surface receptor, HGF binding and e-
Met activation. As a seemingly repetitive process, one may expect c-Met to be
desensitized after some time due to the continuous presence of HGF. Indeed, sorne
receptors possessing an intrinsic tyrosine kinase activity are downregulated following
activation by ligand (Ullrich and Schiessinger, 1990). The downregulation or
desensitization is present in ce!ls to avoid overstimulation of the downstream
signaling cascades which could lead to cellular transformation. Two main
mechanisms are possible; the receptor internalization via coated pits and the
ubiquitin-proteasome degradation. Jeffers and collaborators have shown that the
proteasorna! activity is crucial for c-Met degradation after an acute stimulation with
hepatocyte growth factor (HGF) (Jeffers et ai., 1997). The ubiquitination followed by
degradation which constitutes this proteasomal activity, ensures a short haif-life for
Met receptors and thus helps prevent any c-Met overstimulation. When lactacystin,
an inhibitor of proteasorne activity was used, degradation of c-Met was blocked.
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Based on these observations and previous resuits illustrating that, in steady state
conditions, there is an equal concentration of surface c-Met receptors for MSV
MDCK-INV ceils (with a continuous activation of c-Met) as their parental MSV
MDCK and MDCK ceils (Vadnais et al., 2002), we can postulate that there is no
proteasomal activity in the MSV-MDCK-INV ceil une. This could help explain their
tumoral phenotype. It would be interesting to demonstrate this hypothesis by
studying the ubiquitination level and the c-Met haif-life upon stimulation with HGF
in the three celi unes, especially the MSV-MDCK ceils. Ubiquitination and
degradation of c-Met are expected in MSV-MDCK ceils upon HGF treatment.
Vadnais and collaborators have already observed a rapid tyrosine phosphorylation of
c-Met followed by a decrease in phosphorylation 3 hours following treatment in these
MSV-MDCK celis (Vadnais et al., 2002). The loss of a receptor following
proteasomal degradation could be involved in this phenomenon. Unfortunately, the
level of c-Met receptors was not deternined in the aforemcntioned series of
experiments due to a lack of appropriate antibodies capable of recognizing c-Met
through a Western Blot. For this reason, no conclusions can be drawn witb absolute
certainty. It would however be of great interest to investigate this aspect further.
The specific activation of downstream signalling events represents another possibility
behind c-Met activation which resuits in turnorigenic properties. By using the specific
inhibitor U0126 and LY294002, our research group bas shown that both the ras
MEK-ERK and Pl3kinase-Akt pathways are highly activated in MSV-MDCK-INV
ceils as compared to MDCK celis. Moreover, both pathways have been shown to be
involved with celi motility and invasion (resuits not yet published). However, recent
resuits obtained by treating MSV-MDCK-INV ceils with high concentrations of anti
HGf to block c-Met activation have shown that, although ftilÏy active in the absence
of serum, ERKI/2 activation (phosphorylation) is independent of c-Met activation.
Furthermore, Akt activation in MSV-MDCK-INV celis is dependent on serum,
suggesting that c-Met activation by the autocrine loop is flot sufficient to activate the
P13-kinase-Akt patbway. These resuits thus suggest that the autocrine HGF loop is
activating one or more undefined signailing pathway(s) such as rac and
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MEK3,6/p38MA that may be responsible, in large part, for the motile and invasive
phenotype. A study performed by our research group in collaboration with I.R. Nabi
bas recently shown tbat 3$MAPK downstream of activated rho is involved with
blebbing, pseudopod formation and ceil rnotility (Jia et al., 2003). Other similar
pathways may exist and should be examined in future experirnents.
Conclusion
In this study, we demonstrated the tumoral phenotype of MSV-MDCK-INV cells
through their capacity to grow in anchorage-independent environments. In addition,
our findings suggest that point mutations in neither the C-terminal or the tyrosine
kinase dornains may explain the transformed phenotype observed among MSV
MDCK celis and the invasive/tumoral phenotype observed arnong MSV-MDCK-INV
celis. Our resuits lead to the conclusion that the major rnechanism leading to the
activation of the kinase dornain of c-Met. to invasion and to the tumoral phenotype
observed among MSV-MDCK-INV ceils, although not exclusive, would be the
autocrine HGf activation ioop (Vadnais et aÏ., 2002). The rnechanism involved in
transformation by the Moloney sarcoma virus was however ilot elucidated.
Continued work on these cells with regards to their tumoral characteristics can prove
to 5e very useful in the field of both fundamental research and clinical medicine. By
establishing their capacity to form tumors in nude mice, we can introduce a new
tumorigenic cellular model which can be used in research laboratories to study the
mechanisms behind cancer and metastasis and as well, to assess the effect of anti-
cancer drugs on reducing or eliminating the incidence of cancer. In addition,
continued studies of c-Met can prove extremely valuable in understanding more
deeply how this oncogene is involved with cancer. Due to the seemingly important
role that mutations in c-Met play in certain cancers, it would be interesting to
establish diagnostic kits which could help identify, from the beginning, mutations in
c-Met, especially those involved with metastasis. This would lead to a more hopeful
prognosis that could eventually present metastases spreading throughout the body.
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